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Abstract 
Selenium (Se) is associated with insulin resistance and may affect endothelial 
function thereby increasing the risk of type 2 diabetes and associated cardiovascular 
disease (CVD). However, the molecular mechanisms involved are not clear. The 
endoplasmic-reticulum (ER) stress response is a mechanism involved in apoptosis 
induced by high Se in some cancer cells and, also in the pathogenesis of insulin 
resistance and endothelial dysfunction (ED). Thus, we hypothesised that high Se 
status causes ED through ER stress response. Endothelial cells (HUVECs) and 
EA.hy926 cell lines were treated with selenite (0.5-10 µM) for 24 hours in the 
presence or absence of the ER chemical chaperone, 4-phenylbutryic acid (PBA). ER 
stress markers were investigated using qPCR and western-blot technique. 
Endothelial function was assessed by the Griess assay, flow cytometry, Matrigel® 
and colourimetric assays. Data were expressed as S.E.M (p<0.05) vs. control.  
High Se concentration (5-10 µM) compared to physiological concentration 
(0.5–2.0 µM) enhanced mRNA expression of ER-stress markers:- activating 
transcription factor-4 (ATF4), CAAA/enhanced-binding homologous protein (CHOP) 
and X-binding box-1 (XBP-1). In addition, high selenite concentration reduced nitric 
oxide production and angiogenic capacity in endothelial cells. Moreover, high 
selenite treatment significantly (p<0.05) increased production of reactive oxygen 
species (ROS) and induced apoptosis through caspase-3/7 activity.   
Interestingly, PBA completely reversed all the effects of high selenite on 
endothelial function, indicating the involvement of the ER-stress response. High Se 
treatment caused endothelial dysfunction through the activation of the ER-stress 
response. This thesis additionally warns the public to be aware of the risks of the use 
of Se supplements as a prophylactic agent against oxidative-stress disease.  
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1. Introduction 
 
Cardiovascular disease (CVD) is prevalent in westernised countries and 
continuously increasing in the developing world making CVD a public-health 
concern. Several cellular and molecular mechanisms involved in CVD, including 
oxidative stress, have been investigated.  Recently, the endoplasmic reticulum (ER) 
stress mechanism has been linked to endothelial dysfunction and CVD (Tabas, 
2010; Galán et al., 2014; Lenna, Han and Trojanowska, 2014; Wang et al., 2015). 
The use of anti-oxidants has been trialled to prevent chronic diseases caused by 
oxidative stress (Lippman et al., 2009; Goodman et al., 2011; Rayman, 2012). 
Selenium (Se), which is required for the synthesis of the anti-oxidant selenoproteins 
(Brenneisen, Steinbrenner and Sies, 2005; Lipinski, 2011), has been used to reduce 
the effects of oxidative stress in various disease states including cancer, 
neurodegenerative disorders, type 2 diabetes mellitus (type 2 diabetes) and CVD 
(Rayman, 2012; Pillai, Uyehara-Lock and Bellinger, 2014). However, increasing 
evidence from human, animal and in vitro studies suggests that both low and high Se 
concentrations are associated with an increased risk of type 2 diabetes (Bleys, 
Navas-Acien and Guallar, 2007; Bleys et al., 2008; Labunskyy et al., 2011; Rayman 
et al., 2012; Rayman and Stranges, 2013; Rocourt and Cheng, 2013; Zhou, Huang 
and Lei, 2013). Although type 2 diabetes is intimately linked with endothelial 
dysfunction and vascular wall disease, more experimental work is essential to 
elucidate fully the effect of Se in endothelial dysfunction and CVD risk.  
Inappropriately high (>200 g/day) or low (<55 g/day) Se intake may 
increase the risk of oxidative stress disease and has the potential to induce ER 
stress (Stranges et al. 2010).  Several studies have linked ER stress to insulin 
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resistance and type 2 diabetes (Araki, Oyadomari and Mori, 2003; Ozcan et al., 
2004, 2006; Hummasti and Hotamisligil, 2010).  
Although Se has been implicated as a risk factor for  type 2 diabetes and CVD ( 
Stranges et al. 2010; Stranges et al. 2007; Steinbrenner et al. 2011; Laclaustra et al. 
2010; Rayman & Stranges 2013; Rayman 2012; Bleys, Navas-Acien & Guallar 
2008), few studies have linked the role of Se-induced ER stress to the aetiology or 
progression of type 2 diabetes or other human diseases (Wu et al., 2005; Zu et al., 
2006; Hwang et al., 2007; Wallenberg et al., 2014). Moreover, the role of Se-induced 
ER stress on endothelial dysfunction or diabetes-associated complications such as 
cardiovascular disease is not known.  
 
1.1 Selenium and selenium sources  
 
Se exists in small amounts in foods predominantly as organic forms, [e.g. seleno-
methionine (SeMet) and seleno-cysteine (SeCys)] and very small amounts of 
inorganic forms [selenate (SeO4
-2), selenite (SeO3
-2)]. The highest amounts being 
found in Brazil nuts, fish and offal (e.g. kidney) (Rayman, 2012; Mehdi et al., 2013). 
Sodium selenite and selenate are major sources in dietary supplements. Se levels in 
foods vary across countries depending on the content of Se in the soil in which foods 
are grown and its bioavailability (Labunskyy, Hatfield and Gladyshev, 2014; Roman, 
Jitaru and Barbante, 2014). The richest source of Se is Brazil nuts however the main 
sources of Se in United Kingdom (UK) are bread and cereals, meat and poultry (see 
Figure 1.1) (Rayman, 2012). The UK is considered relatively Se deficient due to the 
low levels of Se in soils (Johnson, Fordyce and Rayman, 2010). Daily Se intake 
varies from country to country, from Se deficient (e.g. in the Keshan area of China) 
to toxic levels (Thomson, 2004). The Se concentration required for optimal 
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glutathione peroxide function, specifically GPx3, in human serum or plasma, is 
around 1-1.2 µM which equates to a Se intake of some 55 µg/day (Thomson, 2004).  
 
Figure 1.1. Sources of Se in the UK. .Meat and poultry and bread and cereals are the main 
source of Se in the UK (Rayman, 2012)  
 
1.2 Selenium metabolism 
 
Inorganic forms of Se (selenite and selenate) are reduced to hydrogen selenide by 
glutathione and thioredoxin reductase (TXNRD3) then converted into 
selenophosphate and finally incorporated into the Seryl-tRNA[ser]sec for synthesis of 
selenoproteins (Roman, Jitaru and Barbante, 2014; Burk and Hill, 2015). The organic 
form of Se, SeMet, is demethylated to selenocysteine and further metabolized to 
hydrogen selenide (Burk and Hill, 2015). At the same time, SeMet can replace 
methionine in a non-specific manner; this means that a high intake of SeMet (e.g. 
from cereal sources or supplements) can appear in blood incorporated into albumin 
or haemoglobin, appearing to raise Se status.  However, such Se is inert until the 
proteins are catabolized and the SeMet is made free for conversion into 
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selenoproteins via selenocysteine and hydrogen selenide (Burk and Hill, 2015). 
Figure 1.2 summarizes the metabolism of Se forms for synthesis of selenoproteins. 
As dietary intake increases from deficient to adequate, excess Se is stored in tissues 
(as SeMet in body proteins) and the rest is excreted via the urine or the skin. 
Excessive intake of Se can result in a pro-oxidant state; toxic levels (>1mg) cause 
selenosis (Dennert et al. 2012) (Vinceti et al. 2001). All Se compounds, once 
converted to hydrogen selenide can lead to increased selenoprotein synthesis (Burk 
and Hill, 2015). As Se dietary intake increases from deficient to adequate, excess Se 
is stored in tissues and the rest is excreted via the urine (Burk and Hill, 2015). 
 
Figure 1.2. Selenium metabolism in human and animals. Sources of Se from diet or 
supplements. Selenomethionine (SeMet) is incorporated into proteins in a non-specific 
manner as well as being capable of being metabolised to selenocysteine (SeCys). SeMet, 
SeCys, selenite and selenate are all broken down into hydrogen selenide (H2Se). H2Se is 
metabolically active and can further be used to synthesise different selenoproteins such as 
selenoprotein P (SELENOP). Excess Se is excreted via the skin, urine and breath (adapted 
from Rayman, Infante and Sargent, 2008; Burk and Hill, 2015).  
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1.2.1. Selenoprotein Synthesis. 
 
Selenoproteins contain one Sec, the 21st amino acid, in their sequences (Arnér, 
2010; Mehdi et al., 2013) with the exception of selenoprotein P (SELENOP). 
SELENOP has up to ten Sec residues including an N-terminal Sec-containing 
thioredoxin domain (Roman, Jitaru and Barbante, 2014). Selenoprotein synthesis is 
reduced when Se dietary intake is deficient or restricted (Labunskyy, Hatfield and 
Gladyshev, 2014). Co-translational incorporation of Sec into proteins is imposed by 
an in-frame UGA codon present in active site of selenoprotein mRNAs (Burk and Hill, 
2015). Sec is introduced into selenoproteins by a complex mechanism that requires 
serine, seryl-tRNA synthase and trans-acting protein factors, Sec-tRNA [Ser]Sec and a 
Sec-insertion-sequence (SECIS) element (Arnér, 2010; Labunskyy, Hatfield and 
Gladyshev, 2014; Burk and Hill, 2015).  
 
The SECIS element transforms the UGA codon from a stop codon to a 
selenoprotein coding sequence (Arnér, 2010; Burk and Hill, 2015). Sec is coded for 
by the Trsp gene in the TATA box position 34 to form tRNA[Ser]Sec which gets 
aminoacylated by serine to form seryl-tRNASer]Sec (Arnér, 2010; Labunskyy, Hatfield 
and Gladyshev, 2014; Burk and Hill, 2015). Hydrogen selenide from dietary 
metabolism reacts with seryl-tRNASer]Sec in the presence of O-phosphoseryl- 
tRNASer]Sec kinase to produce O-phosphoseryl- tRNASer]Sec  which is a 
selenophosphate. Selenocysteryl-tRNA Ser]Sec is synthesized by selenocysteine 
synthase from O-phosphoseryl- tRNASer]Sec; the Selenocysteryl-tRNA Ser]Sec is a 
transfer RNA that is incorporated into the SECIS element for coding and synthesis of 
selenoproteins such as glutathione peroxidase-2 (GPx2) (Labunskyy, Hatfield and 
Gladyshev, 2014; Burk and Hill, 2015).  
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Figure 1.3 highlights a three-way synthesis step of selenoproteins from 
hydrogen selenide in the presence of a tRNA specific for selenoprotein synthesis, 
SECIS binding protein 2 (SBP2) and co-factors such as nucleolin (Arnér, 2010; 
Labunskyy, Hatfield and Gladyshev, 2014). Other than dietary levels and Se intake,  
it has been proposed that different SECIS-binding proteins such as nucleolin, 
eIF4alpha3 and SBP2, regulate the insertion of Sec on proteins for selenoprotein 
synthesis (Arnér, 2010; Labunskyy, Hatfield and Gladyshev, 2014) however, the 
exact mechanism of regulation of Sec incorporation into proteins is complex and is 
yet to be understood. For example, two studies showed that SBP2 is the main 
SECIS binding protein regulating selenoprotein synthesis (Squires et al., 2007; 
Miniard et al., 2010). Although both studies agree on the function of SBP2 in 
selenoprotein synthesis, the involvement of other SECIS binding proteins such as 
nucleolin, could not be confirmed. Understanding the mechanism by which Sec is 
incorporated into proteins is still evolving; nonetheless it can be agreed that 
regulation of selenoprotein synthesis does not only depend on Se dietary intake but 
also on Sec incorporation.  
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Figure 1.3. Selenocysteine and selenoprotein synthesis. The formation of selenoproteins 
requires the formation of an amino acid, selenocycteine, a unit of selenoproteins. 
Selenocycteine is co-translationally inserted in response to the UGA codon with Se insertion 
sequence (SECIS) to be read as a selenoprotein coding codon instead of a stop codon. The 
process starts with serylation of tRNA[ser]sec by seryl-tRNA synthase followed by 
phosphorylation of serine to phosphoseryl-tRNA[ser]sec
 
and lastly, phosphoseryl-tRNA is 
converted to selenocysteryl-tRNA by selenocycteine synthase. Selenocysteryl-tRNA[ser]sec, 
SECIS binding protein (SBP2), selenocycteine elongation factor (IFsec), eukaryotic intiation 
factor 4α (eIF4α) and nucleolin bind to the SECIS and code for the translation of 
selenoproteins such as glutathione peroxidase-2 (Papp et al., 2007; Arnér, 2010). 
 
1.2.2. Functions of Selenoproteins 
 
Human selenoproteins are encoded by 25 genes encoding 25 selenoproteins (Papp 
et al., 2007; Labunskyy, Hatfield and Gladyshev, 2014; Roman, Jitaru and Barbante, 
2014). With few exceptions, all functioning selenoproteins have Sec inserted on 
either the N or C-terminus of the active sites and have redox-active functions (Papp 
et al., 2007). However, the Sec is not only limited to redox-active functions but has 
diverse biological functions as shown in Table 1.1 (Huang, Rose and Hoffmann, 
2012).  Among the 25 well-characterised selenoproteins, the most relevant for this 
study are the glutathione peroxidases (GPXs), thioredoxin reductases (TXNRDs), 
iodothyronine deiodinases (DIOs), SELENOP, selenoprotein S, selenoprotein F 
(formerly known as 15kDa-selenoprotein) and selenoprotein K (Mehdi et al., 2013; 
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Roman, Jitaru and Barbante, 2014). Selenoproteins have been recently named with 
new abbreviations with major changes in renaming selenoproteins F,I,O,P, S and T 
(Regina et al., 2016). Their functions include antioxidant defence, formation of 
thyroid hormones, DNA synthesis, maturation of semen, modulation of Ca2+ influx in 
immune cells (Verma et al., 2011; Rayman, 2012; Mehdi et al., 2013; Roman, Jitaru 
and Barbante, 2014). Selenoproteins such as selenoprotein S, M and selenoprotein 
K,  have been linked to cytosolic calcium regulation,  protein folding and degradation 
of misfolded proteins in the ER because they reside in the ER (Reeves, Bellinger 
and Berry, 2010; Roman, Jitaru and Barbante, 2014). 
 
SELENOP is one of the important selenoproteins in human health; it is 
produced in liver and used to transport Se (Roman, Jitaru and Barbante, 2014). It 
has also been implicated in the pathophysiology of insulin resistance, endothelial 
dysfunction and type 2 diabetes (Misu et al., 2010; Yang et al., 2011; Ishikura et al., 
2014). Elevated levels of SELENOP have been found to impair insulin signalling and 
dysregulate glucose metabolism in hepatocytes. Treating hepatocytes with purified 
SELENOP produced from mouse liver, induced the reduction of insulin-stimulated 
phosphorylation of insulin receptor and protein kinase (Akt) (Misu et al., 2010). 
Moreover, SELENOP increased phosphorylation of IRS1 at ser307, a negative 
regulator of tyrosine phosphorylated IRS-1 (Misu et al., 2010). However, SELENOP 
alone did not alter gluconeogenic enzymes or mRNA encoding glucose production in 
the absence of insulin (Misu et al., 2010). The research showed that SELENOP 
modulated insulin signalling and resulted in impaired angiogenesis due to impaired 
insulin-dependent NO production (Ishikura et al., 2014).  
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Glutathione peroxidase 1 (GPX1) is the most abundant selenoprotein in 
mammals and its function is to reduce hydrogen peroxide and organic 
hydroperoxides in the cytosol and mitochondria (Arnér, 2010; Labunskyy, Hatfield 
and Gladyshev, 2014) . GPX1 has been shown to have insulin mimetic effects in 
hepatocytes (Stapleton, 2000). Mice overexpressing GPX1 are obese and present 
with hyperglycaemia and hyperinsulinaemia (McClung et al., 2004), which indicates 
that GPX1 overexpression leads to insulin resistance. Insulin resistance was thought 
to result from the reduction in insulin-stimulated phosphorylation of the hepatic and 
muscle insulin substrate receptor and Akt observed in GPX1 overexpressing mice 
compared to wild type (McClung et al., 2004). 
 
Selenoprotein S (SELENOS) is an ER-resident selenoprotein which is 
involved in protein folding, elimination of misfolded proteins from the ER and also in 
regulating inflammation (Mehdi et al., 2013; Labunskyy, Hatfield and Gladyshev, 
2014). Se deficiency results in an abnormal redox state causing several disorders 
related to oxidative stress such as cancer,  type 2 diabetes and CVD (Rayman 2005; 
Stranges et al. 2010; Rayman 2012; Baum et al. 2013). Table 1.1 summarises  the 
25 human selenoproteins  identified and characterised from  the literature  (Huang, 
Rose and Hoffmann, 2012).
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Table 1.1. Summary of selenoproteins and their functions in humans (Huang, Rose and Hoffmann, 2012). 
Selenoprotein Abbreviation(s) Function and significance 
Cytosolic glutathione 
peroxidase 
GPX1 GPX1 knockout is susceptible to oxidative challenge. Overexpression of GPX1 
increases risk of diabetes. 
Gastrointestinal glutathione 
peroxidase 
GPX2 GPX1/GPX2 double-knockout mice develop intestinal cancer; one allele of GPX2 
added back confers protection. 
Plasma glutathione peroxidase GPX3 Important for cardiovascular protection, perhaps through modulation of nitric oxide 
levels; antioxidant in thyroid gland. 
Phosholipid hydroperoxide 
glutathione peroxidase 
GPX4 Genetic deletion is embryonic lethal; GPX4 acts as crucial antioxidant, and sensor 
of oxidative stress and pro-apoptotic signals; required for spermatozoa function 
Olfactory glutathione 
peroxidase 
GPX6 Importance unknown. 
Thioredoxin reductase type I TXNRD1 Localized to cytoplasm and nucleus. Genetic deletion is embryonic lethal. 
Thioredoxin reductase type II TXNRD2 Localized to mitochondria. Genetic deletion is embryonic lethal. 
Thioredoxin reductase type III TXNRD3 Testes-specific expression. 
Deiodinase type I DIO1 Important for systemic active thyroid hormone (T3) production. 
Deiodinase type II DIO2 Important for local active thyroid hormone (T3) production. 
Deiodinase type III DIO3 Inactivates thyroid hormone. 
Selenoprotein H SELENOH Nuclear localization, involved in transcription. Essential for viability and antioxidant 
defence in Drosophila. 
Selenoprotein I SELENOI Possibly involved in phospholipid biosynthesis. 
Selenoprotein K SELENOK Transmembrane protein localized to ER and involved in calcium flux in immune 
cells. 
Selenoprotein M, 
Selenoprotein 15 
SELENOM Thiol-disulfide oxidoreductase localized to ER. Possibly involved in protein-folding. 
 
Selenoprotein N SELENON Potential role in early muscle formation; involved in RyR-related calcium 
mobilization from ER. 
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Selenoprotein Abbreviation(s) Function and significance 
Selenoprotein O SELENOO Contains a Cys-X-X-Sec motif suggestive of redox function, but importance 
remains unknown. 
Selenoprotein P SELENOP Se transport to brain and testes—SELENOP knockout leads to neurological 
problems and male sterility. SELENOP also functions as intracellular antioxidant in 
phagocytes. 
Selenoprotein R 
Methionine-R-sulfoxide 
reductase 1 
MsrB1 Functions as a methionine sulfoxide reductase and SELR knockouts show mild 
damage to oxidative insult. 
Selenoprotein S SELENOS Transmembrane protein found in plasma membrane and ER. Reduces ER stress. 
Selenoprotein T SELENOT ER protein involved in calcium mobilization. 
Selenoprotein V SELENOV Testes-specific expression. 
Selenoprotein W SELENOW Putative antioxidant role, perhaps important in muscle growth. 
Selenophosphate synthetase  SELENOP2 Involved in synthesis of all selenoproteins, including itself. 
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Recently, high Se intake (from supplementation) and higher Se status have 
been implicated as risk factors for type 2 diabetes (Bleys, Navas-Acien and Guallar, 
2007; Rayman, 2012). Se has been shown to have a non-linear, partial U-shaped 
association with diabetes as well as with all-cause mortality (Figure 1.4) (Bleys, 
Navas-Acien and Guallar, 2007) indicating that both low and high Se status may 
contribute to human disease. However, the molecular and cellular mechanisms 
underlying these paradoxical effects of Se are yet to be fully investigated. 
 
Figure 1.4. Serum Se in human disease. Figure 1.4 A shows the relationship between low 
and high Se status and odds ratio for developing type 2 diabetes in the USA population 
whereas Figure 1.4 B shows the U-shaped association between serum Se and all-cause 
mortality from the US National Health and Nutrition Examination Survey (Bleys, Navas-Acien 
and Guallar, 2007). 
 
1.3. Selenium in human health and disease 
 
Se exerts its anti-oxidative-stress actions through the enzymatic activity of Se in 
GPXs and TrxRs, and to a lesser extent through other selenoproteins (Rayman, 
2012; Labunskyy, Hatfield and Gladyshev, 2014). The addition of Se to food, 
fertilisers and dietary supplements has increased in many countries around the world 
particularly in western countries such as the UK and USA, because of the scientific 
evidence that Se may reduce the risk of diseases linked to oxidative stress (Zhou, 
Huang and Lei, 2013). Human and animal studies have shown some benefits of Se 
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on cancer incidence, immune function, brain function, fertility and reproduction, 
thyroid function and viral suppression (Rayman, 2012). The effect of Se status on 
type 2 diabetes is controversial. A U-shaped relationship between Se status and type 
2 diabetes has been observed (Labunskyy et al., 2011; Rayman and Stranges, 2013; 
Xin-liang et al., 2016). Moreover, the impact of Se status on CVD is also 
controversial and therefore needs further investigation.  
1.3.1. The impact of selenium in type 2 diabetes and type 2 diabetes-
associated CVD  
 
Several studies have shown that Se has contradictory effects on cardio-metabolic 
disease (Bleys, Navas-Acien and Guallar, 2007; Bleys et al., 2008; Labunskyy et al., 
2011; Rayman et al., 2011; Stranges et al., 2011). The effect of Se on diabetes has 
been controversial as both low and high Se status have been shown to be 
associated with heightened diabetes risk in animal and human studies (Bleys, 
Navas-Acien and Guallar, 2007; Mueller et al., 2009; Labunskyy et al., 2011; 
Rayman, 2012). Low serum and erythrocyte Se concentrations have been observed 
in type 1 and type 2 diabetes patients (Kljai and Runje, 2001). This study 
demonstrated that diabetic patients had significantly lower serum Se (< 59.23±12.2 
µg/L) than non-diabetics whose mean serum Se was 64.2±11.5 µg/L (Kljai and 
Runje, 2001). Four years later, Rajpathak and colleagues, 2005, showed that toenail 
Se concentration, a biomarker for dietary Se, was lower in diabetics with or without 
cardiovascular complications than in healthy men (Rajpathak et al., 2005). 
Additionally Parks and colleagues (K. Park et al., 2012) found that higher levels of 
toenail Se among generally healthy American men and women were associated with 
lower incidence of type 2 diabetes; however the result does not exclude the harm or 
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benefits of high Se intake on type 2 diabetes. The potential mechanism(s) involved in 
the increased risk Se in diabetes need to be clarified 
 
1.3.2. Definition of Insulin resistance, endothelial dysfunction and Type-2 
diabetes and associated CVD 
 
Type 2 diabetes is intimately associated with CVD chiefly because of the complex 
interplay between insulin resistance and endothelial dysfunction (Gage et al., 2013; 
Rajendran et al., 2013; Wang et al., 2013). Endothelial dysfunction is the initial step 
in development of macro- and micro-vascular complications (Levick, 2003; 
Rajendran et al., 2013; Wang et al., 2013). Type 2 diabetes is a complex metabolic 
disorder which is characterised by inability of the body to control glucose as a result 
of defects in insulin secretion or insulin action (Drouin et al., 2013). Diabetes has 
become a leading health problem especially in developed countries with an 
estimated 360 million people diagnosed worldwide. It has been estimated that by 
2025, five million people will have diabetes in the United Kingdom (UK) and currently 
over three million people are diabetic, 90% of whom suffer from type 2 diabetes and 
10% of whom live with type 1 diabetes (www.diabetes.org.uk). Type 2 diabetes is 
characterised by hyperglycaemia and insulin resistance (Stanley, 1999). Insulin 
resistance is generally considered as the hallmark of the development of type 2 
diabetes (McClung et al., 2004). 
  
Growing evidence suggests that insulin resistance promotes dyslipidaemia, 
hypertension and inflammation to induce several components of the metabolic 
syndrome and promote progression to CVD, including heart failure and vascular 
dysfunction (McCarthy, 2010; Drouin et al., 2013). CVD is the number one cause of 
death globally, representing 31% of all global deaths with 7.4 million and 6.7 million 
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deaths due to coronary heart disease and stroke respectively (WHO, 2015). The 
American Heart Association reported in 2015 that approximately 65% of diabetic 
patients die of CVD (Mozaffarian et al., 2015). Moreover, the American Heart 
association estimates that 27 in 1000 adults aged 60+ years are at risk of a fatal 
coronary heart disease or heart attack (Mozaffarian et al., 2015). In the UK, the 
primary cause of death and disability in diabetic patients is CVD, accounting for 52% 
of deaths in diabetes (Sarwar et al., 2010; Diabetes UK, 2015). The cost of treating 
CVD in the UK is £6.8 billion with CVD death rates of 33/100 000 in the National 
Health Service between 2012 and 2013 (Bhatnagar et al., 2015). Insulin resistance, 
a marker of type 2 diabetes, is an independent factor of CVD (Lebovitz, 2001; Cox et 
al., 2014). Diabetic patients have twice the risk of developing CVD than non-diabetic 
patients. In addition, 20% of  hospital admission for stroke, heart failure and heart 
attack are in diabetic patients (Diabetes UK, 2015).  
 
Several factors concurrently influence the predisposition to the development 
of type 2 diabetes and CVD. Among these factors are sedentary lifestyle, western-
type diet, hypertension, genetic factors and ageing (Stanley, 1999; McClung et al., 
2004; Cox et al., 2014) with obesity being the most common underlying factor (Hu, 
2011; Nguyen et al., 2011). Obesity is a result of imbalance between calories 
consumed and calories disbursed resulting in increased accumulation of fat around 
the body (WHO  2013). Obesity accounts for 80-85% of the risk of development of 
type 2 diabetes (Hu, 2011). Excess adipose tissue increases levels of pro-
inflammatory cytokines (leptin and tumour necrosis-factor alpha) and non-esterified 
fatty acids (NEFAs) to impairs insulin signalling transduction (Watanabe, Nagai and 
Takatsu, 2013). The released NEFAs circulate in the plasma leads to increased free 
glycerol and therefore very low density lipoproteins. Elevated VLDL and NEFAs 
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impair endothelial function and raise blood pressure (Watanabe, Nagai and Takatsu, 
2013). The relationship between NEFA and insulin resistance has not been well 
clarified; a systemic review of the effect of NEFA in insulin resistance showed that 
NEFA is not necessary associated with IR (Karpe, Dickmann and Frayn, 2011). 
However, Insulin resistance increases fatty acid production resulting in increased 
lipid peroxidation. Increased activation of lipid oxidation induces inflammation in the 
vascular walls resulting in impaired endothelial function and eventually insulin 
resistance (Karpe, Dickmann and Frayn, 2011), Activation of inflammation in type 2 
diabetes increases the risk of CVD via impaired function of the endothelium (Wang 
et al., 2013). 
1.3.3. Endothelial dysfunction  
 
The endothelium is composed of a monolayer of endothelial cells that line the entire 
innermost tunica intima of all vessels in the body. It is recognised as being an 
endocrine organ able to sense mechanical and hormonal changes in the blood, but 
also to secrete various mediators and hormones (Rajendran et al., 2013). 
Endothelial cells regulate vascular homeostasis through the control of various 
vascular functions including angiogenesis, regulating vasodilators and 
vasoconstrictors, smooth muscle cell proliferation and the maintenance of blood 
fluidity by balancing levels of pro-coagulants and anti-coagulants (Rajendran et al., 
2013). Nitric oxide (NO) is one of the vasodilators produced continuously by 
endothelial cells. NO has physiological roles in the cardiovascular, neurologic and 
immune systems and the generation of NO is directed from multiple pathways 
(Levick, 2003). 
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One of the important pathways of NO production is through the insulin binding 
to the Insulin receptor substrate-1 (IRS-1) (Shankar et al., 2000; Wang et al., 2013). 
Insulin binds to the IRS-1 activating its auotphosphorylation which later forms a 
dimer with the phosphatidylinositol 3-kinase-dependent (P(I)3K). Phosporylation of 
P(I)3K actvates the  phosphorylation of PDK that inturn phosphorylates the protein 
kinase B (Akt) (Shankar et al., 2000; Wang et al., 2013). Akt directly phosphorylates 
endothelial nitric oxide synthase at serine-1177 resulting in ijncreased eNOS  activity 
and production of NO (Shibuya, 2011; Wang et al., 2013; Johnson and Wilgus, 
2014). Impaired insulin signalling leads to reduced insulin-induced NO production 
and reduced glucose uptake in the skeletal muscles resulting in endothelial 
dysfunction and hyperglycaemia (Kubota et al., 2011). Increased glucose levels lead 
to activation of inflammation, which is implicated in cardiac insulin resistance and 
CVD (Basha et al., 2012; Mandavia et al., 2013).  
 
 In relation to the cardiovascular system, a physical stimulus such as shear 
stress or bradykinin activates the generation of NO from L-arginine to L-citrulline by 
stimulating the phosphorylation of endothelial NO synthase (eNOS) and releasing 
NO (Levick, 2003; Cunningham and Gotlieb, 2005; Hermann, Flammer and Lscher, 
2006). Additionaly, the synthesis of NO can be stimulated during hypoxia to induce 
endothelial cell migration, motility and maturation and angiogenesis (Shibuya, 2011; 
Carnicer et al., 2013). Hypoxia activates the hypoxia inducing factor-1 alpha (HIF-1α) 
which is a transcription factor for the vascular endothelial growth factor (VEGF-A) 
(Shibuya, 2011). The VEGF-A produced by the surrounding cells (pericytes), as a 
result of stimuli such as hypoxia in tumourigenesis or in the process of tissue repair, 
binds to the VEGF receptor-2 on the endothelial cells stimulating the 
phosphoyrylation of eNOS via the P(I)3K pathway (Shibuya, 2011; Johnson and 
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Wilgus, 2014). P(I)3K results in the phosphorylation of protein kinase B (Akt) which 
in turn activates eNOS by donating its phosphate to produce NO in the endothelial 
cells (Johnson and Wilgus, 2014). At the same time, stimulation of the 
VEGFreceptor-2 (VEGF-R2) triggers the activity of phospholipase C (PLCγ) which 
catalyses the breakdown of inositol trisphophate  (IP3). IP3 activates the Ca
2+ 
channels and relases the stored Ca2+ from the ER to the cytoplasm, increasing the 
cytosolic Ca2+. Increased cytosolic Ca2+ stimualtes Ca2+/calmodulin kinase, inducing 
phosphorylation of eNOS and resulting in NO production (Levick, 2003). Figure 1.5 
summarises the synthesis of NO by endothelial cells. 
Figure 1.5. Mechanism by which endothelial cells produce NO. VEGF stimulated by 
physiological stimuli e.g hypoxia inducing factor 1α (HIF-1α) during tumourigenesis or tissue 
repair, binds to the VEGF receptor 2 activating the phosphorylation of the  phospholipae C 
(PLCγ), triggering the increase of the cytosolic Ca2+ from the ER and inducing the 
intercalation of the Ca2+ calmodulin (Ca2+/CaM) channel to the eNOS (Figure 1.5A). In 
addition, various stimuli such as shear stess, VEGF-A binding and insulin signalling trigger 
the activation of the phosphoinositide 3-kinase pathway (P(I)3K) resulting in the 
phosphoryaltion of protein kinase B (Akt) and eNOS. Also, eNOS cleaves from L-arginine to 
produce L-citruline and NO (Figure 1.5B). NO is a major vasodilator and important activator 
for angiogenesis, inhibtion of inflamatory respose and leukocyte proliferation (Levick, 2003; 
Shibuya, 2006). 
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NO available from the endothelial cells acts on guanyl cyclase to produce 
3′,5′-cyclic guanosine monophosphate to act on vascular smooth muscles cells, 
resulting in vasodilation (Hermann, Flammer and Lscher, 2006; Luiking, Engelen and 
Deutz, 2010; Rajendran et al., 2013). In addition, the function of NO is to prevent 
platelet aggregation, exert anti-inlfammatory effects on leukocytes and promote the 
formation of new vessels or capillaries from pre-exisiting vessels; this process is 
known as angiogenesis (Luiking, Engelen and Deutz, 2010) and provides protection 
from atherosclerosis (Dimmeler et al., 1999; Cunningham and Gotlieb, 2005; 
Hermann, Flammer and Lscher, 2006).  
 
Disturbances in glucose and lipid metabolism associated with the insulin 
resistant state leads to increased production of reactive oxygen species (ROS) and  
reactive nitrogen species in addition to the activation of several inflammatory 
pathways within the body (Donath and Shoelson, 2011). ROS, specifically 
superoxide anion (O2), can react with nitric oxide (NO), a marker and key player in 
functions mediated by endothelial cells, and reduce the bioavailability NO, leading to 
impaired endothelial cell function including angiogenesis (Roberts and Sindhu, 
2009). Because insulin directly stimulates the production of NO in endothelial cells, 
disrupted insulin signalling may disturb endothelial function by reducing NO 
bioavailability (Bashan et al., 2009; Rains and Jain, 2011). Hence, insulin resistance 
in the endothelium is associated with reduced insulin-stimulated NO production 
contributing to micro and macro vascular complication in diabetic patients (Gage et 
al., 2013). Vascular complications associated with type 2 diabetes are grouped as 
microvascular and macrovascular. Microvascular complications include retinopathy, 
diabetic nephropathy and neuropathy which all are resultant of impaired 
angiogenesis (Fowler, 2011; Gage et al., 2013). 
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Angiogenesis is an important feature in normal physiology and several 
pathological processes that promotes and enhances the formation of new blood 
vessels from pre-existing vessels (Carmeliet, 2005). Angiogenesis is tightly regulated 
by the pro-angiogenic and anti-angiogenic factors that act on endothelial cells to 
induce or inhibit endothelial growth and migration in order to initiate angiogenesis 
(Adams and Alitalo, 2007). Vascular endothelial growth factor (VEGF-A), platelet 
activating factor (PAF) and fibroblast growth factors are important pro-angiogenic 
activators needed for stimulating endothelial cell growth and migration in order to 
initiate angiogenesis (Levick, 2003; Johnson and Wilgus, 2014). VEGF-A is the most 
important molecule controlling the morphogenesis of the blood vessels; it is 
abundant in tissues consistently forming new vessels such as tumours, diabetic 
retina, myocardium and endothelium (Adams and Alitalo, 2007; Johnson and Wilgus, 
2014). Studies have shown that VEGF resistance leads to impaired angiogenesis in 
type 2 diabetes resulting in development of various vascular complications 
associated with type 2 diabetes (Shibuya, 2011) however the molecular mechanism 
is not fully understood.  Yang and colleagues showed that high glucose induced 
apoptosis in endothelial cells through down regulation of VEGF mRNA expression 
(Yang et al., 2008). The study showed that pre-treating cells with endogenous 
VEGF-A prevented apoptosis mediated by high glucose (Yang et al., 2008).  
 
1.3.4. Is selenium involved in cardio-metabolic disorders? 
 
The use of anti-oxidants has been trialled to prevent chronic diseases caused by 
oxidative stress (Lippman et al., 2009; Goodman et al., 2011; Rayman, 2012). 
Dietary supplements such as the trace element Se, which is required for the 
synthesis of the anti-oxidant selenoproteins (Brenneisen, Steinbrenner and Sies, 
2005; Lipinski, 2011) have been used to reduce the effects of oxidative stress in 
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various disease states including cancer, neurodegenerative disorders, type 2 
diabetes and CVD (Rayman, 2012; Pillai, Uyehara-Lock and Bellinger, 2014). 
However, increasing evidence from human, animal and in vitro studies suggests that 
both low and high Se concentrations are associated with increased risk of type 2 
diabetes and CVD (Bleys, Navas-Acien and Guallar, 2007; Bleys et al., 2008; 
Labunskyy et al., 2011; Rayman et al., 2012; Rayman and Stranges, 2013; Rocourt 
and Cheng, 2013; Zhou, Huang and Lei, 2013) making inappropriately high or low 
Se status yet another risk factor for cardio-metabolic disorders.  
 
1.3.5. The impact of Se on type-2 diabetes and CVD risks; observational 
studies 
 
A non-linear association between Se and type 2 diabetes has been observed. The 
Selenium and Vitamin E Cancer Trial (SELECT) was designed to investigate the 
effect of 200 µg/day of Se and 400 IU of vitamin E on the incidence of prostate 
cancer (Lippman et al., 2009).  SELECT results revealed a statistically non-
significant increase (relative risk=1.07, p=0.16) in the risk of diabetes in men taking 
Se supplementation alone compared to the placebo group alone and Se combined 
with vitamin E group (Lippman et al., 2009). In 2011 another meta-analysis of 
SELECT study showed a beneficial effect of Se supplementation on prostate cancer 
risk but type-2 diabetes and CVD risks have not yet been investigated in the updated 
results (Klein et al., 2011). However, further secondary analysis of the SELECT trial 
after 7 years of follow up showed a 17% increased risk of prostate cancer in men 
taking vitamin E alone but showed no type 2 diabetes risk suggesting that vitamin E 
may have a long term effect on prostate cancer risk only (Klein et al., 2011). An 
evaluation of twenty-five observational studies showed that a 50% increase in Se 
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concentration was associated with a 24% reduction in CVD risk (Flores-Mateo et al., 
2006). In observational studies, Se status was inversely associated with CVD risk 
(Flores-Mateo et al., 2006; Klein et al., 2011). However, as observational studies do 
not measure the effect of an intervention (Se) with an outcome (CVD risk), 
randomised controlled trials are more suitable for the assessment of Se on CVD 
risks.   
 
1.3.6. The impact of Se in type-2 diabetes and CVD risk; randomised controlled 
trials (RCTs) 
 
High Se intake has been found to increase the risk of type 2 diabetes. A non-linear 
association between Se and type 2 diabetes has been observed. One systemic 
review observed a positive association between serum Se levels in populations with 
low and high Se levels (Xin-liang et al., 2016). The study showed that there was a 
significant prevalence of type 2 diabetes in a population with high blood Se 
compared to populations with low blood Se levels (p<0.05, p=0.003) (Xin-liang et al., 
2016). In addition, serum Se was positively associated with type 2 diabetes in 
populations with low serum Se, <97.5 µg/L (<0.5 µM) (Xin-liang et al., 2016). The 
Nutritional Prevention of Cancer (NPC) trial was designed to investigate the effect of 
Se supplementation on non-melanoma skin cancer among the 1312 men from low 
Se areas of Eastern United States of America (USA). Despite the fact that Se 
supplementation given as 200 µg/day of high-Se yeast showed a protective role 
against prostate cancer, the post hoc analysis of the trial showed that long term Se 
intake at 200 µg/day increased the risk of diabetes (Stranges et al., 2007). Men with 
baseline serum Se more than 121.6 ng/mL given long-term supplementation with Se 
had dysregulated glucose metabolism and insulin resistance (Stranges et al., 2007).  
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In the UK, Se supplementation in the UK PRECISE trial had no effect on the 
risk of type 2 diabetes as measured by plasma adiponectin in elderly participants 
with low plasma Se (Rayman et al., 2012). Adiponectin is a hormone secreted by 
adipocytes that is independently associated with decreased risk of diabetes, CVD, 
hypertension and dyslipidaemia (Spranger et al., 2003; Yamamoto et al., 2014). In 
participants with a mean plasma Se of 90.8 g/L  treated with 100, 200 and 200 
µg/day of Se-yeast, there was no effect on adiponectin levels after six months of 
treatment (Rayman et al., 2012). The effect of Se on type 2 diabetes is controversial. 
Randomised controlled trials show contradictory results, however  animal and cell 
culture experiments shows that high Se levels impair insulin signalling leading to 
insulin resistance (Stranges et al., 2007; Rayman et al., 2012; Cold et al., 2015). 
Considering that insulin resistance is closely linked to endothelial dysfunction and 
increased risk of CVD, the role of Se in endothelial dysfunction and CVD risk has 
attracted attention (Bleys et al., 2009; Laclaustra et al., 2010; S. Stranges et al., 
2010). 
 
In humans, Se deficiency is thought to be linked to Keshan disease, an 
endemic cardiomyopathy found in the Chinese region of Keshan where Se intake 
was extremely low as a result of deficient Se intake (Chen et al., 2012). A meta-
analyses study shows that Se deficiency increases the risk of CVD and that long-
term Se deficiency adversely affects heart function (Thomson, 2004). Interestingly, 
high Se intake and levels have been implicated in the development of CVD 
(Rajpathak et al., 2005; Flores-Mateo et al., 2006; Bleys et al., 2008; Laclaustra et 
al., 2010; Saverio Stranges et al., 2010; Rayman et al., 2011). The UK PRECISE 
results contradict the NPC trial results because the two populations had different 
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baseline plasma Se levels. The baseline Se of the NPC trial was 121.6 ng/mL 
whereas the UK population baseline mean plasma Se was 90.8 µg/L. . The Se 
supplementation might therefore be beneficial for the low-Se population of the UK 
compared to the adequate-Se population of the USA. Also, the UK PRECISE trial 
assessed adiponectin as a marker of type 2 diabetes instead of glucose levels or 
insulin as compared to NPC trial which used confirmed diagnosis of type 2 diabetes. 
However, it shows that Se is associated with type 2 diabetes risk.  
 
In addition to the association of Se status and type diabetes risk, Se status is 
also linked to CVD risk. Secondary analysis of the NPC trial assessing the incidence 
of myocardial infarction, total cerebrovascular accidents and CVD from low-Se areas 
of the eastern USA did not show an overall benefit of 200 µg/day of Se 
supplementation in the prevention of CVD during 7.6 years of follow-up (Stranges et 
al., 2006). A meta-analysis of the NPC and SELECT trials showed that there was no 
proof that Se supplements prevent CVD therefore further trials of Se 
supplementation in Se adequate population are discouraged (Rees et al., 2013). 
 
1.3.7. Selenium status and lipid profiles 
 
In comparison to RCTs with Se-containing supplements, studies on Se 
supplementation and plasma lipids also show contradictory results based on the Se 
status of the population studied (Bleys et al., 2008; Laclaustra et al., 2010; Saverio 
Stranges et al., 2010; Rayman et al., 2011; Cold et al., 2015). One RCT in a 
population of relatively low Se status supplemented with 100, 200 and 300 µg 
Se/day concluded that Se supplementation had small beneficial effects on plasma 
lipids in that population (Rayman et al., 2011). Six months Se supplementation 
reduced the total cholesterol and non-HDL cholesterol levels in 100 and 200 µg/day 
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group compared to the placebo (Rayman et al., 2011). Although the total cholesterol-
HDL cholesterol ratio decreased progressively with increased Se doses, there was a 
moderate increase in HDL levels in the population given 300 µg/day of Se compared 
to placebo  (Rayman et al., 2011). Interestingly, a Danish study in which 468 
subjects aged between 60 and 74 years were supplemented with 100, 200 and 300 
µg/day of Se (as high-Se yeast) for up-to 5 years, found a significant increase in 
plasma Se levels and a significant decrease in total cholesterol in the supplemented 
groups compared to the placebo group (Cold et al., 2015). In addition there was a 
small non-significant difference in the total:HDL-cholesterol ratio, non-HDL-
cholesterol and HDL-cholesterol after 6 months and 5 years of Se supplementation 
(Cold et al., 2015). In comparison to the UK PRECISE study, the Danish PRECISE 
study did not show any benefit of Se supplementation over placebo after 6 months or 
5 years of Se supplementation.  
 
Although the two European studies performed in low Se status countries 
showed contradictory results on the benefits of Se supplementation on 
serum/plasma lipids, studies conducted in USA showed a positive association of 
serum Se with levels of plasma lipids (Bleys et al., 2008; Laclaustra et al., 2010). 
Cross-sectional analysis of the NHANES III observational study investigating the 
relationship between Se intake and the lipid profile of a representative sample of 
USA adults aged between 19-64 years found a positive association between high 
serum Se and serum concentrations of total cholesterol, low density cholesterol, high 
density cholesterol, triacylglycerol, apolipoprotein B and apolipoprotein A-I (Bleys et 
al., 2008). The results showed that participants with more than 147 µg/L of serum Se 
had high levels of plasma lipids compared to those with low baseline serum Se 
levels (124 µg/L). In the NHANES III, data collected between 2003 and 2004 showed 
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that high serum Se levels were associated with increased concentrations of total and 
LDL cholesterol (Laclaustra et al., 2010); a similar trend was observed in NHANES 
III from data collected between 1988-1994 (Bleys et al., 2008). 
 
The literature review reveals contradictory effects of Se supplementation on CVD 
suggesting that experimental work is needed to clarify the effect of high Se levels on 
CVD. Altogether, these findings suggest that high Se intake may be associated with 
cardio-metabolic risk, particularly of insulin resistance, a hallmark of type 2 diabetes 
and endothelial dysfunction; however, the underpinning molecular mechanisms are 
not yet fully elucidated.  
 
1.4. Molecular mechanisms involved in Se-induced insulin resistance  
 
A study comparing the action of Se to that of insulin suggested that Se (500 -1000 
µM, as selenate), has insulin-mimetic effects by promoting the phosphorylation of the 
β-subunit of the insulin receptor substrate and insulin receptor 1 (Stapleton et al., 
1997). However, the study did not specify if the selenate supplementation was done 
in Se-deficient or adequate conditions (Stapleton et al., 1997). Furthermore, as 
selenoproteins are scavengers of ROS, it has long been understood that low Se 
status leads to increased accumulation of ROS and reduced insulin sensitivity. On 
the other hand, Wang and others found that high Se intake caused activation of 
selenoproteins, including glutathione peroxidase and SELENOP, which led to an 
influx of free fatty acids into rat liver and a dramatic increase in ROS production 
resulting in impaired insulin signalling and hepatic insulin resistance (Wang et al., 
2014).  Recently, Zeng reported that prolonged high intake of dietary Se increased 
the expression of GPx1 in a dose-dependent manner and caused insulin resistance, 
hyper-insulinaemia and glucose intolerance in gestating rats (Zeng et al., 2012). 
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High Se intake was shown to induce glucose and insulin intolerance in rat 
models by disturbing the insulin-signalling pathway and enhancing gluconeogenesis 
in rat liver and hepatocytes (Wang et al., 2014). High levels of Se, as methylseleninic 
acid (MSA), were able to activate several selenoproteins leading to enhanced 
lipolysis in adipose tissue and to an influx of free fatty acids in rat liver (Wang et al., 
2014).  This led to the accumulation of ROS as a result of an excessive supply of 
electrons for mitochondrial oxidative phosphorylation (Wang et al., 2014). This study 
indicates that high Se may lead to insulin resistance through the impairment of ROS 
regulation. Increased ROS, particularly of hydrogen peroxide (H2O2), can activate 
several Ser/Thr protein kinases such as IKKβ, PKC, JNK and p38, which can then 
phosphorylate insulin receptor substrates (IRS)-1/2 on serine residues (Ser302, 
Ser307 and Ser612). This can inhibit the capacity of IRS-1/2 to associate with the 
insulin receptor which then suppresses the recruitment and thus activation of PI3-K 
leading to the impairment of the insulin-signalling pathway (Tiganis, 2011). 
 
The interaction of insulin with its receptor leads to a short activation of 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, a membrane 
complex responsible for superoxide production. Superoxide produced by NADPH 
oxidase will be reduced to H2O2 under the action of superoxide dismutase. H2O2 can 
then interact and thus inactivate two phosphatases: – protein tyrosine phosphatase 
1B (PTP1B) and phosphatase and tensin homolog (PTEN). PTP1B is a negative 
regulator of a substrate receptor-1 (IRS-1).  IRS-1 is kept inactive by insulin-induced 
H2O2 to enhance insulin signalling. The inhibition of PTEN and PTP1B by insulin-
induced H2O2 will therefore enhance the insulin response.  Low levels of H2O2 
activate PTEN and PTP1B. PTEN dephosphorylates PIP3 into PIP2 thus reducing the 
activation of the Akt enzyme downstream of the insulin receptor signalling pathway. 
Page 44 of 167 
 
Increased amounts of selenoproteins following high Se intake will quench the insulin-
induced H2O2 and therefore leave PTP-1B and PTEN phosphatases active, leading 
eventually to impairment of the insulin signalling pathway (Steinbrenner, 2013). 
Figure 1.6 summarizes these mechanisms. 
 
Figure 1.6. Potential influence of Se on the insulin cascade. Physiological levels of 
reactive oxygen species (H2O2) keep both PTEN and the PTP1B inactive. However, high Se 
levels and increased selenoproteins (SelP and GPx1) quench ROS produced thus activating 
PTP1B and PTEN. Active PTP1B prevents tyrosine phosphorylation of IRS-1 and active 
PTEN dephosphorylates PIP3 inhibiting Akt. Altogether, activation of PTP1B and PTEN 
impairs insulin signalling (Steinbrenner, 2013). 
 
 
In recent years, several cancer studies have shown an association between 
high Se intake and the activation of a recently recognised metabolic pathway called 
ER stress (Wu et al., 2005; Zu et al., 2006; Hwang et al., 2007). High Se 
concentrations were shown to cause ER-stress-mediated cell death by increasing 
mobilization of calcium and caspases-3 and 9 (Uguz and Naziroglu, 2012). 
Interestingly, ER stress has also been shown to be activated in animal models of 
obesity and diabetes and to be implicated in impairing the insulin signalling pathway 
and causing hepatic insulin resistance (Ozcan et al., 2004). Overexpression of ER 
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stress markers has been observed in liver and adipose tissue from obese and 
diabetic animals and in humans (Hotamisligil, 2010; Hummasti and Hotamisligil, 
2010). Furthermore, ER stress has also been reported to play a key role in the 
development of endothelial dysfunction in animal models of diabetes and 
atherosclerosis (Kassan et al., 2012). However, the role of ER stress in insulin 
resistance or endothelial dysfunction mediated by high Se has never been 
investigated. 
 
1.5. Endoplasmic Reticulum (ER) Stress  
 
The ER is a multi-functional organelle important for cellular homeostasis. One of the 
critical functions of ER is to sequester calcium (Ca2+) from the cytosol back to the ER 
leading to calcium storage at high concentrations as recently reviewed by Schwarz  
(Schwarz and Blower, 2016). ER has both smooth and rough components; the 
smooth ER is mainly for lipid synthesis and metabolism while the rough ER controls 
the synthesis, folding and structural manufacturing of proteins that are eventually 
secreted or lodged in the Golgi apparatus (Schwarz and Blower, 2016), Proteins and 
plasma membranes are translated in the ER membrane-associated ribosome also 
known as the rough ER followed by transportation to the ER lumen (Schwarz and 
Blower, 2016). This makes the ER an important organelle in proteostasis, a quality 
control process in the cell that keeps proteomes functional (Flamment et al., 2012). 
Disturbances to the function of the ER lead to accumulation of misfolded or unfolded 
proteins in the ER lumen (Schröder and Kaufman, 2005) and this is known as ER 
stress. Accumulation of unfolded proteins lead to the activation of a pro-survival 
cellular response called the unfolded protein response (UPR). The purpose of UPR 
is to recover ER homeostasis and enhance cell survival (Schröder and Kaufman, 
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2005). However, if the response is insufficient, the UPR is prolonged, resulting in ER 
stress and cells may become dysfunctional and undergo apoptosis (Schröder and 
Kaufman, 2005; Flamment et al., 2012). 
 
The three stress-sensing proteins found on the ER membrane are normally 
kept bound to the immune-globulin protein (BiP) also known as Glucose regulated 
protein 78 (GRP78) to be inactive under normal conditions and cell function 
(Schröder, 2008; Hetz, 2012). Three stress-sensing proteins found on the ER 
membrane are involved in the UPR response: the inositol-requiring enzyme (IRE-
1α), the protein kinase RNA-like ER kinase (PERK) and activating transcription factor 
6 (ATF6) (Schröder and Kaufman, 2005; Flamment et al., 2012). During UPR, BiP 
detaches to bind to misfolded proteins, activating the three stress-sensing proteins 
(PERK, ATF6 and IRE-1α) (Schröder and Kaufman, 2005; Flamment et al., 2012). 
Activated PERK phosphorylates eukaryotic initiation factor 2 (eIF2α), attenuates 
protein translation, reduces the load of new protein synthesis and prevents further 
accumulation of unfolded proteins within the ER. 
 
Activated ATF6 cleaves to form ATF6 protease of 50kDA (ATF6p50). 
ATF6p50 transcription factor enhances the expression of chaperone genes, such as 
BiP, to increase the folding capacity within the ER (Hetz, 2012). Activated IRE-1α 
triggers the activation of X-box binding protein (XBP-1) for cellular maintenance 
(Schröder and Kaufman, 2005; Flamment et al., 2012; Inagi, Ishimoto and Nangaku, 
2014). Paradoxically, chronic activation of the UPR promotes selective translation of 
activating transcription factor 4 (ATF4) by phosphorylated eIF2α. ATF4 induces 
expression of the pro-apoptotic protein CAAA/EBPα-homologous protein (CHOP) 
and activates the expression of growth arrest and DNA damage-inducible protein 
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(GADD34) (Schröder and Kaufman, 2005; Inagi, Ishimoto and Nangaku, 2014). 
Activation of GADD34 results in a feedback loop as it interacts with protein 
serine/threonine phosphatase (PP1) to dephosphorylate eIF2α in order to restore 
global protein translation and suppress ATF4 translation to basal levels (Ma and 
Hendershot, 2003). However, more experimental work is needed to further confirm 
the role of GADD34 as a regulator of ER stress. Nonetheless, constant activation of 
ER stress leads to irreversible ER damage resulting in cell apoptosis (Tabas and 
Ron, 2011; Hetz, 2012). As shown in Figure 1.7, chronic UPR further activates 
apoptosis through the mitochondrial apoptosis pathway.  
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Figure 1.7. The UPR pathway. BiP dissociates from the luminal side of PERK, IRE1 and 
ATF6 thus activating them. Activated PERK phosphorylates eIF2α and inhibits protein 
translation to recover the cell and also increases translation of ATF4, a transcription factor 
that activates expression of several UPR target genes in favour of cell survival. Prolonged 
UPR due to sustained ER stress induces apoptosis through the activation of CHOP, an 
apoptotic marker and GADD34. Activation of IRE1 triggers its endo-ribonuclease activity to 
induce splicing of XBP-1 mRNA to produce a spliced form of XBP-1mRNA (sXBP-1). sXBP-
1 is an active transcription factor that activates the expression of Regulated IRE1 dependent 
decay (RIDD) microRNA, which partake in the ER-associated protein degradation. Also 
RIDD, regulates the expression of chaperones in order to enhance folding and degradation 
of misfolded proteins. In addition, IRE1 activates phosphorylation of ASK-1 and JNK which 
recruits TRAF2 which are implicated in apoptosis during sustained ER stress (adapted from; 
(Hetz, 2012). 
 
 
Unresolved ER stress initiates transcriptional up-regulation and inhibition of 
the B cell lymphoma 2 (BCL-2) family of protein (BAX, BAK and BCL-2 proteins) 
which are known to inhibit or promote apoptosis (McCullough et al., 2001; Hitomi et 
al., 2004; Urra et al., 2013). ER stress is known to further trigger the activation of the 
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pro-apoptotic proteins, BAX and/or BH antagonist killer (BAK),and at the same time 
inhibit BCL-2 protein to trigger caspase dependent apoptosis (McCullough et al., 
2001; Hetz, 2012). Activation of a pro-apoptotic marker of ER stress, CHOP, 
promotes the transcriptional upregulation of BCL-2-interacting-mediator of cell death 
(BIM) and down regulates the expression of BCL-2 protein (Hetz, 2012). Up-
regulation of BIM and inhibition of BCL-2 proteins activates cytosolic release of 
cytochrome c that in turn causes the activation of the caspase cascade to initiate 
apoptosis (Szegezdi et al., 2006). Caspases are a family of endoproteases that 
regulate cell death; they are the cysteine proteases that cleave specific aspartic acid 
resides (Morishima et al., 2002). Caspases involved in apoptosis are classified by 
their mode of action as either initiator (caspase-8 and -9) or effector caspases 
(caspase-3, -6 and -7) (Kroemer and Martin, 2005).  Cytochrome c binds to the 
apoptotic protease-activating factor-1 (APAF1) to form an apoptosome which recruits 
the initiator caspase-9 (Elmore, 2007). Activated caspase-9 cleaves the pro-
caspases-3 and -7 to initiate DNA fragmentation, chromatin condensation and 
nuclear degradation leading to apoptosis (Elmore, 2007; Fuchs and Steller, 2011).  
 
Caspases-3 and -7 have been implicated in ER-stress-induced apoptosis 
(Morishima et al., 2002; Cheung et al., 2006; Tabas and Ron, 2011). In mouse 
models cytochrome c release activates caspase-12 and induces ER-stress-mediated 
apoptosis (Morishima et al., 2002). However, caspase-12 is lacking in humans and 
instead ER-stress-mediated apoptosis in human cells is thought to be initiated by the 
activation of caspase-8 which cleaves caspase-3 and -7 to trigger ER-stress-
mediated programmed cell death (Hetz, 2012). At the same time activation of the 
IRE1α pathway leads to induction of the inflammatory and pro-apoptotic signalling 
pathways such as c-Jun terminal kinases (JNK), apoptosis signal-regulating kinase 
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(ASK1) and TNF-α receptor associated factor 2 (Inagi, Ishimoto and Nangaku, 
2014). JNK is known to phosphorylate BCL-2 leading to the suppression of BCL-2; 
inhibited BCL-2 activates release of the cytochrome c to activate the intrinsic 
apoptosis pathway (Szegezdi et al., 2006). Moreover, recruitment of the ASK1 
protein leads to the initiation of apoptosis through a complex mitogen-activated 
protein kinase MAPKs-JNK-ASK1 signalling pathway which activates caspase-8 
downstream, an initiator caspase which then activates effector caspases-3 and -7 
(Zuo et al., 2004).  In addition, activated IRE1α controls ER protein-loading by 
degrading ER-associated microRNA (miRNA) known as IRE1-dependent decay 
(RIDD). The ability of activated IRE1α to switch from splicing XBP-1 to 
endoribonuclease activity is regulated by the threshold of the ER stress. During high 
or chronic ER stress,  IRE1α  is activated to degrade RIDD miRNA more that to 
splice the XBP-1 mRNA to prevent ER mRNA overloading (Hetz, Chevet and Oakes, 
2015).  
 
1.5.1 ER stress inhibitors; uses of chemical chaperones 
 
Dysfunction of the calcium regulation in the ER or abnormal accumulation of mis-
folded proteins due to increased production of proteins or lipid inaugurates ER stress 
(Hetz, 2012). The use of chemical chaperones has been shown to prevent and 
reduce protein mis-folding and ER stress (Ozcan et al., 2006; Kuang et al., 2010; 
Kim et al., 2013; Liu et al., 2016). Sodium 4-phenylbutyric acid (PBA) is a short-chain 
unsaturated fatty acid which has chemical chaperone properties (Humeres et al., 
2014). PBA has been shown to improve ER folding and trafficking and therefore 
reduces ER stress (Ozcan et al., 2006; Kuang et al., 2010; Liu et al., 2016). 
Extensive research has been done to show the ability of PBA to restore proteostasis 
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of the protein called cystic fibrosis transductance regulator which is prone to 
misfolding and when misfolded causes cystic fibrosis (Balch et al., 2008). Hence, 
PBA has been studied and developed as a treatment of cystic fibrosis. Other than for 
fibrosis, PBA has been shown to reverse ER-stress-induced diabetes in the obese 
Zucker rat (Ozcan et al., 2006).  
 
One study showed that upon infection of astrocytes with the ts1 virus, there 
was accumulation of gPr80env in the ER, initiating the UPR and a subsequent chain 
of ER-stress events to cause cystic fibrosis (Liu et al., 2004). Moreover another 
study showed that ts1 infected astrocytes resist accumulation of the gPr80env when 
treated with 5 and 10 mM of PBA, emphasising the importance of PBA in prevention 
of ER-stress induction in astrocyte cells (Kuang et al., 2010) . Additionally, PBA was 
shown to suppress UPR target genes such as BiP and ER stress markers such p-
eIF2a and ATF4 in ts-1 infected astrocytes (Kuang et al., 2010). It did this by 
increasing the protein-folding capacity rather than the degradation of misfolded 
proteins further accentuating the role of PBA as a chemical chaperone that prevents 
ER stress (Kuang et al., 2010). It is well established that tunicamycin and 
thapsigargin are ER-stress inducers that initiate ER stress by inhibiting glycosylation 
of proteins on the N-linked glycan and inhibit sarco/ER calcium ATPase, respectively 
(Kubota et al., 2006). Several studies have shown that PBA prevents ER stress 
induced by thapsigargin and tunicamycin in different cell lines such as astrocytes, 
murine cardiac fibroblast and hepatocytes (Liu et al., 2004; Ozcan et al., 2006; 
Kuang et al., 2010; Humeres et al., 2014).  
 
ER stress is associated with conditions such as neurodegenerative disease, 
cancer, diabetes and CVD as well as being implicated in atherosclerosis plaque 
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rupture (Ozcan et al., 2006; Myoishi et al., 2007; Tabas, 2009; Kuang et al., 2010; 
Wang and Kaufman, 2012).  In recent years, it has been shown that several 
metabolic situations, such as obesity and diabetes, increase the demand for protein 
synthesis in the ER in the liver and other insulin-sensitive tissues, leading to an ER-
stress response and thereby contributing to the development of insulin resistance 
and endothelial dysfunction (Ozcan et al., 2004; Jeschke et al., 2012). The three 
arms of the UPR are intimately linked to inflammatory pathways participating in the 
development of insulin resistance and eventually endothelial dysfunction.  
 
Previous studies have implicated ER stress in the pathogenesis of hepatic 
insulin resistance  as well as atherosclerosis (Hotamisligil, 2010). Conditions such as 
increased protein synthesis observed in obesity and other insulin-resistant states 
lead to ER dysfunction (Araki, Oyadomari and Mori, 2003; Ozcan et al., 2004; 
Sharma et al., 2008). It has been shown that a high-fat diet and pharmacologically-
induced ER stress in mice and cultured hepatocytes, respectively, result in increased 
expression of protein tyrosine phosphatase (PTP)1B protein and its mRNA. PTP1B 
is a notorious negative regulator of insulin signalling as it can dephosphorylate 
tyrosine residues on the insulin receptor and IRS1/2 (Delibegovic et al., 2009; 
Agouni et al., 2011). Agouni and colleagues  showed that liver-PTP1B-deficient mice 
had reduced hepatic ER stress response when fed a high-fat diet and were more 
insulin sensitive than their wild-type littermates (Agouni et al., 2011). 
 
ER stress has been implicated as one of the mechanisms involved in insulin 
resistance through the activation of IRE1-dependent-JNK and nuclear factor kappa B 
(NF-κB) (Ozcan et al., 2004; Hummasti and Hotamisligil, 2010; Ozcan and Tabas, 
2012).  IRE1-dependent-JNK leads to inhibition of insulin signalling by inactivating 
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tyrosine phosphorylation of the insulin receptor; increases phosphorylation of the 
IRS-1/2 on serine307 in insulin sensitive cells and organs, particularly liver and 
adipose tissue resulting in insulin resistance (Ozcan et al., 2004; Hummasti and 
Hotamisligil, 2010; Ozcan and Tabas, 2012). Chemical chaperones, 
tauroursodeoxycholic acid (TUDCA) and PBA, have been shown to reverse ER 
stress, restore glucose metabolism and improve insulin sensitivity in type 2 diabetic 
mouse models (Ozcan et al., 2006; Yam et al., 2007; Amin et al., 2012). Additionally, 
young diabetic mice treated with TUDCA showed reduction in ER stress markers as 
well as increased levels of adiponectin and high circulating amounts of cholesterol 
and C-reactive protein, suggesting an improved metabolic function in adipose tissue 
and liver, thus preventing impaired ischaemia-induced neovascularization (Amin et 
al., 2012). The use of chemical chaperones to reverse impaired insulin signalling 
highlights the role of ER stress in insulin resistance.  
 
1.6. The role of ER stress in endothelial dysfunction and cardiovascular 
disease 
 
Several studies have implicated ER stress in the development of atherosclerosis  
(Erbay et al., 2009; Hotamisligil, 2010; Flamment et al., 2012; Chistiakov et al., 
2014). Expression of the ER-stress markers, ATF4 and XBP-1, was increased in 
macrophages loaded with cholesterol (Li et al., 2005); furthermore, ER stress 
markers, CHOP and BiP, were elevated in ruptured atherosclerotic plaques from 
human coronary artery autopsy samples (Myoishi et al., 2007). Macrophage 
apoptosis is a major process in the progression of advanced atherosclerosis and cell 
models show that prolonged ER stress is responsible for CHOP-mediated 
macrophage apoptosis through ER release of calcium and Ca2+/calmodulin-
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dependent protein kinase II (CaMKII) (Ozcan and Tabas, 2012). Studies mentioned 
indicate that the ER stress response is linked to the development of atherosclerosis 
and can increase the risk of CVD. Although ER stress is implicated in endothelial 
dysfunction, the role of ER stress in the vasculature is yet to be fully validated. 
 
A number of studies on cultured endothelial cells, animal models and humans 
have linked ER stress to endothelial dysfunction (Sheikh-Ali et al., 2010; Basha et 
al., 2012; Kassan et al., 2012; Ozcan and Tabas, 2012; Galán et al., 2014). 
Homocysteine has been found to be a risk factor in CVD and in cultured endothelial 
cells; homocysteine has been found to activate CHOP via the IRE1 pathway 
resulting in ER-stress-mediated endothelial-cell death (Zhang et al., 2001).  
Moreover,  one study found elevated mRNA ER stress markers, IRE1 and ATF6, in 
anatomical sites marked with atheroma and reduced blood flow from pig aortic 
arches (Davies et al., 2013), thereby associating ER stress activation with disturbed 
shear stress. Shear stress is defined as ―a biomechanical force determined by blood 
flow‖ (Cunningham and Gotlieb, 2005). Disturbed shear stress leads to endothelial 
dysfunction due to low endothelial NO-synthase (eNOS) production, low vasodilation 
and low endothelial repair coupled with increased ROS and apoptosis. Endothelial 
dysfunction as a preceding factor for atherosclerosis eventually results in ischemic 
injury and CVD (Cunningham and Gotlieb, 2005).  
  
Angiogenesis is one of the markers of endothelial dysfunction and current 
studies have shown an involvement of ER stress markers in the angiogenesis 
process (Dong et al., 2011; Lenna, Han and Trojanowska, 2014; Urra and Hetz, 
2014; Binet and Sapieha, 2015). GRP78/BiP overexpression has been reported in 
the synovium of rheumatoid arthritis patients, in contrast to mice models in which 
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GRP78/BiP activation was linked to VEGF-induced angiogenesis (Lenna, Han and 
Trojanowska, 2014). One study was investigating the role of GRP78 in tumour 
growth by looking at the early phase of tumour growth called neovascularization, 
also known as tumour angiogenesis; the study found that in heterozygote GRP78+/- 
mice implanted with E0771 breast cancer cells, there was a 70% reduction in  
tumour angiogenesis compared to GRP78 +/+ mice (Dong et al., 2011). The results 
showed not only that ER stress is involved in tumour angiogenesis but 
overexpression of ER-stress markers inhibits angiogenesis in the early phases of 
cancer compared to the late phase of tumour implantation (Dong et al., 2011).  In 
addition experimental evidence suggests that ER stress might be involved in 
endothelial dysfunction and diabetes associated vascular complications (Basha et 
al., 2012). Anti-oxidants have been used as a therapy for the oxidative stress 
implicated in type 2 diabetes (Samuel et al., 2010). However, Se (an anti-oxidant as 
selenoproteins) has been shown to have insulin mimetic effects as well as impair 
insulin signalling in insulin sensitive organs (Stapleton, 2000; Steinbrenner et al., 
2011).   
 
High Se levels have a potential to induce ER stress (Wu et al., 2005; 
Wallenberg et al., 2014). Several studies have linked ER stress to insulin resistance 
and type 2 diabetes (Araki, Oyadomari and Mori, 2003; Ozcan et al., 2004, 2006; 
Hummasti and Hotamisligil, 2010). Although Se status has been implicated as a risk 
factor for type 2 diabetes and CVD ( Stranges et al. 2010; Stranges et al. 2007; 
Steinbrenner et al. 2011; Laclaustra et al. 2010; Rayman & Stranges 2013; Rayman 
2012; Bleys, Navas-Acien & Guallar 2008), few studies have linked the role of Se-
induced ER stress to the aetiology or progression of type 2 diabetes or other human 
diseases (Wu et al., 2005; Zu et al., 2006; Hwang et al., 2007; Wallenberg et al., 
Page 56 of 167 
 
2014). Moreover, the role of Se-induced ER stress on endothelial dysfunction or 
diabetes complications such as vascular disease is unknown.  
 
1.7. Selenium-induced ER Stress.  
 
Se has been shown to activate apoptosis in prostate cancer cells through induction 
of ER stress (Wu et al., 2005). In the study by Wu et al., 10 µM  of methylseleninic 
acid (MSA) induced ER stress in the human prostate cancer cell line, PC-3, and 
furthermore induced ER stress-mediated apoptosis in a dose dependent manner 
(Wu et al., 2005). ER-stress markers, phospho-PERK, GRP78/BiP and phospho-
eIF2 were activated by MSA in a time dependent manner from 6 hours to 15 hours. 
Furthermore, while the ER-stress-associated apoptotic markers (cleaved caspase 
12, PARP and CHOP) increased in a dose dependent manner, the markers of ER 
stress (phospho-PERK, GRP78/BiP and phospho-eIF2) decreased (Wu et al., 
2005). Overexpression of GRP78/BiP alleviated MSA-induced ER stress (Wu et al., 
2005). The results shows that chronic ER stress activation leads to cell death. 
Although the chronic ER stress dampens further activation of unfolded protein 
response markers, continuous stimulation of chaperones such as BiP prevents 
chronic ER stress activation.  
 
Recently, a study was carried out to investigate the ability of MSA and 
selenite to induce apoptosis in primary effusion lymphoma (PEL) cell lines which 
concluded that MSA and selenite induce apoptosis through the activation of caspase 
3, caspase 7 and caspase 9 while MSA induces caspase-9 dependent apoptosis 
(Shigemi et al., 2016). Furthermore, MSA and selenite induced apoptosis via the ER 
stress pathway though CHOP expression (Shigemi et al., 2016). High selenite 
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concentration, 20 µM, has been shown to induce apoptosis through the activation of 
ER stress in a time-dependant manner in human acute promyelocytic leukemia 
(NB4) cells (Guan et al., 2009). In spite of reports showing the association between 
ER stress and development of endothelial dysfunction in animal models of diabetes 
and atherosclerosis, the role of ER stress in insulin resistance or endothelial 
dysfunction mediated by high Se has never been investigated. 
 
  
Page 58 of 167 
 
1.8. Hypothesis: 
 
Some epidemiological studies indicate that a supra-nutritional intake of Se correlates 
positively with increased risk of diabetes and associated CVD; however, the 
underpinning molecular mechanisms are not yet elucidated. ER-stress activation has 
been implicated in insulin resistance, endothelial dysfunction and Se-induced cell 
death in prostate cancer cells. Therefore, the hypothesis is that a high intake of Se 
activates the ER-stress response in the endothelium, leading to endothelial 
dysfunction.  
1.9. Aims and Objectives: 
Aim 1. To investigate the effect of Se treatment on the activation of ER stress 
response in cultured endothelial cells and hepato-carcinoma cell lines.  
Objectives: 
1. To determine the dose- and time-response of Se treatment on ER-stress 
activation in cultured hepato-carcinoma cell lines and endothelial cells using 
selenite as source of Se. 
2. To investigate arms of the ER-stress pathway activated by high Se 
concentration in endothelial cells. 
3. To determine the effects of high Se on the viability of endothelial cells and 
hepato-carcinoma cell lines. 
Aim 2. To investigate the role of high-Se-induced ER stress in endothelial cell 
function. 
Objectives: 
1. To investigate the effect of high-Se-induced ER stress on NO availability in 
cultured endothelial cells. 
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2. To determine the impact of Se-induced ER stress on the NO signalling 
pathway using western blot technique in cultured endothelial cells. 
3. To investigate the impact of high Se concentration on ER-stress-mediated 
production of ROS in cultured endothelial cells. 
Aim 3. To determine the effect of high-Se-induced ER stress on the capacity of 
endothelial cells for angiogenesis and apoptosis. 
Objectives: 
1. To determine the effect of high-Se-mediated ER stress on the process of 
angiogenesis using cultured endothelial cells as models. 
2. To investigate the impact of high Se and the involvement of ER stress on 
endothelial-cell death. 
3. To determine the apoptotic pathway involved in the ER-stress-mediated 
apoptosis caused by high Se concentration in cultured endothelial cells. 
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Chapter 2. Materials and Methods 
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2.1. Cells and cell culture 
 
EA.hy926 cell line, a hybrid cloned from the human umbilical vein cells and the A549 
lung carcinomatous cells and HepG2 cells, hepatocellular carcinoma cells,   were 
obtained from the American Type Culture Collection (ATCC). Human umbilical vein 
endothelial cells (HUVECs) were obtained from Lonza (Slough, UK.). EA.hy926 and 
HepG2 cells were routinely cultivated in high glucose (4.5g/L) Dulbecco's Modified 
Eagle's Medium (DMEM) (Sigma, Gillingham, UK.) supplemented with 10% foetal 
bovine serum (FBS; Invitrogen, Paisley, UK.), L-glutamine (2 mmol/L) and 100 
I.U/mL of penicillin and 100 µg/mL of streptomycin. (Sigma, Gillingham, UK.), and 
were maintained at 37 °C in a humidified atmosphere with 5% carbon dioxide (CO2) 
(Agouni et al., 2010). To maintain the cell lines, cells were passaged at 80-90% of 
confluence using trypsin-EDTA (Sigma, Gillingham, UK.), then plated in 25 cm2 
ventilated flasks and six well plates. 
 HUVECs were routinely maintained in M200 media (Gibco® through Life 
Technologies, Paisley, UK). M200 media forms a complete culture environment for 
human large vessel endothelial cells. It contains both essential and non-essential 
amino acids and vitamins. To support the plating and proliferation, the media was 
supplemented with low serum growth supplement (Gibco® through Life 
Technologies, Paisley, UK). The low serum growth supplement (LSGS) components 
included foetal bovine serum, recombinant human basic fibroblast growth factor, 
hydrocortisone, recombinant human epidermal growth factor and antibiotics. 
HUVECS were seeded at cell density of 10,000-20,000 cells/cm2 per well in a 
ventilated T75 cm2. The cells were maintained at 37°C in a 95% humidified 
atmosphere with 5% CO2. Cells were left to reach a 70-80% confluence before 
passing. Cells were detached with StemPro® Accutase® Cell Dissociation Reagent 
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(Gibco® through Life Technologies, Paisley, UK) which is less harsh to human 
primary cell lines than trypsin-EDTA. Media was changed every 48 hours until 
desired confluence was reached. The HUVECs were maintained up to passage 6 
post-recovery. 
 
2.2. MTT viability assay  
 
This assay is based on the conversion of the yellow tetrazolium salt 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to purple formazan 
crystals by metabolically active cells and provides a quantitative estimate of viable 
cells (Vistica et al., 1991). EA.hy926 cell lines, HUVECs and HepG2 cells were 
seeded in 96-well plates (50,000 cells/well), grown for 24 hours, and then treated for 
24 hours with 0.5µM, 2µM, 3µM, 5µM, 10µM, 20µM, 30µM,100µM and 1000µM 
sodium selenite, sodium selenate and seleno-methionine (SelMet)   (Sigma-Aldrich, 
Gillingham, UK). After this period, MTT (Sigma-Aldrich, Gillingham, UK) at the final 
concentration of 0.5 mg/mL was added to each well and incubated for 4 hours at 
37°C, 95% humidified incubator with 5% CO2. Then, 99.7% (v/v) of Dimethyl 
Sulfoxide (DMSO) (Fisher Scientific, USA), was added to each well to solubilise the 
MTT reagent. Spectrophotometric absorbance was measured at 540 nm (reference 
620 nm) using a multi-plate reader. Experiments were performed in sample size of 4 
in 16 replicates, and the relative cell viability (%) was expressed as a percentage 
relative to the untreated control cells.  
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2.3. ER stress induction; time course and dose response of sodium selenite 
 
For Se treatments, HUVECs and HepG2 cells were seeded into 6-well plates at the 
density of 200,000 cells/well or seeded into a well-ventilated T25cm2 at a density of 
500 000 cells/well 24 hours before the treatments. Sodium selenite, sodium selenate 
and seleno-methionine (SelMet) (Sigma-Aldrich, Gillingham, UK) have been reported 
to be used in cell cultures, animal and human studies to study the effects of high Se 
in cancer cells (Rayman, 2005; Goodman et al., 2011; Dennert et al., 2012; S.-H. 
Park et al., 2012). Inorganic Se compounds are mostly used in nutritional 
supplement (Fairweather-Tait, Collings and Hurst, 2010).  To investigate the optimal 
dose and optimal time for Se to induce ER stress in cells, a stock solution of 1 mM 
sodium selenite was prepared by adding 1 g of sodium selenite into 5.8 mL of sterile 
phosphate buffered saline (PBS) and filtered through a 0.2 μm filter. Then, dose-
response and time-course studies were performed in the cells. Briefly, twenty-four 
hours after cells were seeded into 6-well plates at the density of 200,000 cells/well, 
culture media were replaced with fresh complete media (M200 media and LSGS) for 
HUVECs and for EA.hy926 cell lines with 10% FBS DMEM with L-Glutamine (2 
mmol/L),  100 I.U/mL of penicillin and 100 µg/mL of streptomycin. Cells were then 
incubated with sodium selenite at different concentrations ranging from normal 
concentrations to supra-nutritional concentrations of (0.5 -10 µM) at different time 
points (4, 8 and 24 hours) with and without a chemical chaperone PBA (Sigma-
Aldrich, Gillingham, UK).  The cells were finally harvested for different experiments.  
2.4. RNA extraction  
 
To determine the effect of dose-response and time-course of sodium selenite on the 
mRNA expression of various genes including those related to ER stress response, 
HUVECs were seeded at a density of 200,000 cells/well in a 6-well plates and then 
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treated with sodium selenite when they were 60-70% confluent. Cells were treated 
with 0.5, 5 and 10 µM of sodium selenite for 4, 8 or 24 hours. HepG2 cells were 
seeded at a density of 200,000 cells/well in a 6-well plates and then treated with 0.5, 
5 and 10 µM sodium selenite when they were 60-70% confluent for 8 hours. Cell-
culture medium was removed from plates and they were then washed twice with 
1mL of PBS. Total RNA was isolated from HUVECs and HepG2 cells using RNeasy 
Mini Kit (QIAGEN, Manchester, UK). RNeasy technology simplifies total RNA 
isolation by using guanidine-isothiocyanate lysis with the speed and purity of silica-
membrane purification. RNA extraction was performed following the manufacturer‘s 
protocol with a modification of eluting the RNA pellet with 30 µL of nucleic acid-free 
water, leaving to incubate for 10 minutes at room temperature then spinning for 1 
minute at ≥8000 g. RNA was subsequently quantified using a Nanodrop 
spectrophotometer (Thermo Fisher Scientific, Loughborough, UK). 
  
2.5. cDNA synthesis and mRNA gene expression analyses 
 
RNA was then purified by digesting DNA. Briefly, a total of from 200 ng of total RNA 
to 1µg of total RNA was used and mixed in 96-well polymerase chain reaction (PCR) 
plates with 1X reaction buffer, DNase I (Thermo Fisher Scientific, Loughborough, 
UK) and topped up to a total of 10 µL with nucleic acid-free water (Sigma-Aldrich, 
Gillingham, UK). The reaction mixture was digested by heating to 37°C for 30 
minutes in a thermal cycler (Applied Biosystems, UK). The reaction was stopped by 
incubating at 65°C for 10 minutes with 1 µL of 1X EDTA in a thermal cycler.  
 
After DNA digestion, cDNA was synthesised from the same reaction plate. 
Master mixer was prepared containing 5X reaction buffer, Riboblock RNAse inhibitor, 
deoxynucleotide triphosphates (dNTPs) and reverse transcriptase enzyme (Thermo 
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Fisher Scientific, Loughborough, UK) and topped up with nucleic acid-free water to 
make 1X concentration. One µL of Oligo(dT) (Sigma-Aldrich, Gillingham, UK), a 
short sequence of deoxy-thymine nucleotides primer to polymerise to the poly (A) tail 
of the mRNA, was added to each reaction and incubated at 65°C for 5 minutes in a 
thermal cycler (Applied Biosystems, UK). After incubating with Oligo(dT), 8 µL of 
Master Mix were added to make up a total volume of 20 µL and the cDNA was 
synthesised for 1 hour at 42°C in a thermal cycler followed by 5 minutes at 70°C to 
stop the reaction. The cDNA was then diluted 1:10 with Tris-EDTA buffer and used 
for immediate analysis or stored at -80°C until subsequent use. 
 
Targeted genes were amplified by real time PCR (qPCR) using GoTaq® 
qPCR Master mix (Promega Corporations, Madison, USA). GoTaq® qPCR Master 
Mix is a 2X master mix that includes a proprietary dsDNA-binding dye, GoTaq® Hot 
Start Polymerase, magnesium chloride (MgCl2), dNTPs and a proprietary reaction 
buffer excluding cDNA sample and primers of targeted genes (Promega, 2014), as 
previously described (Agouni et al., 2011). A master mix was prepared by mixing the 
following reagents for each sample: 3 µL of nucleic acid-free water, 6 µL of 2X 
GoTaq® qPCR Master mix and 1 µL of forward and reverse primers each. Eight µL 
of prepared master mix was then added to each well containing 2 µL of cDNA 
samples or standard curve samples. Five standards were prepared for each gene by 
serial dilutions of 1:3 of the sample containing both the highest dose of treatment 
making a range of 1:1 to 1:81. The 96-well qPCR plates with samples were spun for 
1 minute at 3,600 g. The samples were then amplified in Applied Biosystems 7500 
instrument for 40 cycles with parameters as follows: 94°C for denaturing (30 
seconds), 60°C (30 seconds) for annealing and 72°C (1 minute) for elongation. 
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Relative gene expression was calculated using the standard curve method. The list 
of primers used in the experiments is shown in Table 2.1. 
 
Table 2.1 List of human forward and reverse primers used in qPCR experiments. 
Target 
Gene 
5′ → 3′ Forward primer 5′ → 3′ Reverse primer 
β-Actin CATGTACGTTGCTATCCAGGC CTCCTTAATGTCACGCACGAT 
BiP CATCACGCCGTCCTATGTCG CGTCAAAGACCGTGTTCTCG 
CHOP GAACGGCTCAAGCAGGAAATC TTCACCATTCGGTCAATCAGAG 
ATF4 CCCTTCACCTTCTTACAACCTC TGCCCAGCTCTAAACTAAAGGA 
VEGF-A  AGGGCAGAATCATCACGAAGT AGGGTCTCGATTGGATGGCA 
 
2.6. Conventional PCR for XBP-1 
 
To further investigate the activation of Se-induced ER stress in HUVECs, spliced and 
unspliced XBP-1 mRNA expression was determined with conventional PCR. The 
size difference between the spliced and the unspliced XBP-1 is 26 base pairs. To 
make PCR products, 0.5 µL of cDNA, 7.5 µL of nuclease free water (Promega 
Corporations, Madison, USA) 10 µL of Gotaq® G2 Hot Start Green Master Mix 
(Promega Corporations, Madison, USA), 2 µL of human XBP-1 forward primer 
5‘CCTTGTAGTTGAGAACCAGG3‘ and reverse primer 
5‘GGGGCTTGGTATATATGTGG3‘ (Sigma-Aldrich, Gillingham UK) were amplified 
with a Techne thermal cycler (Bibby Scientific Ltd, Staffordshire UK ) . The 
amplification process was as follows; 
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Denaturing; 
94 ºC for 5 minutes 
Annealing;  
94 ºC for 30 seconds 
58 ºC for 30 seconds        x40 cycles 
72 ºC for 1 minute 
Extension; 72 ºC for 7 minutes 
Holding stage; 4 ºC indefinitely. 
 
In each experiment, both positive (thapsigargin treated cDNA) and negative 
control samples (no cDNA sample) were included for quality control measures. PCR 
products were electrophoresed on 2.5% agarose gel with 8 µL of Safe View gel 
nucleic acid stain (NBS Biological ltd, UK) and gels were visualized with Gel Doc™ 
EZ Imager (Bio-Rad, USA). 
 
2.7. Western Blot 
 
2.7.1. Protein extraction  
 
After treatments, plates were removed from the incubator and put on ice to keep the 
temperature as close to 4°C as possible to inhibit any enzymatic activity that might 
cause protein degradation (proteases) or dephosphorylation of phosphatases. Media 
were disposed of and cells were carefully washed twice with 1 mL of cold PBS. 
Then, whole-cell lysates were prepared by extraction in 200 µL/well of radioimmuno-
precipitation assay (RIPA) lysis buffer (10 mM Tris-HCl, pH 7.4; 150 mM NaCl; 0.1% 
SDS; 1% Triton-X100; 1% Sodium deoxycholate; 1 mM NaF; 5 mM EDTA; 1 mM 
sodium orthovanadate; cocktail of protease inhibitors (Thermo Fisher Scientific, 
Loughborough, UK) at 4°C (Agouni et al., 2011). The cells were then scraped using 
a cell scraper to collect all the lysates in one corner of the well and then transferred 
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into labelled 1.5 mL micro tubes (Eppendorf) using a 200 µL pipette. The cell lysates 
were then clarified by centrifugation at 4°C for 15 minutes at 14,000 g. The 
supernatant was carefully transferred without disturbing the pellet of cell debris, into 
new labelled 1.5 mL micro tubes. Cell lysates (samples) were assayed for protein 
quantification following procedure on section 2.7.2 and then stored at -20°C until 
further analysis. 
 
2.7.2 Protein assay 
 
Protein concentrations were determined using the colorimetric bicinchoninic acid 
(BCA) assay (Thermo Fisher Scientific, Loughborough, UK). BCA assay is based on 
the principle of reduction of Cu+2 to Cu+ by proteins in an alkaline environment 
(Olson and Markwell, 2007). The BCA assay primarily relies on two reactions; firstly, 
the peptide bonds in protein reduce copper (Cu+2) ions from the cupric sulfate to 
form cuprous cation (Cu+) (a temperature dependent reaction). Secondly, two 
molecules of bicinchoninic acid chelate with each Cu+ ion formed in the first reaction, 
forming a purple-coloured product that strongly absorbs light at a wavelength of 540-
562 nm. The bicinchoninic acid-Cu+ complex is influenced in protein samples by the 
presence of cysteine/cysteine, tyrosine, and tryptophan side chains. At higher 
temperatures (37 to 60°C), peptide bonds assist in the formation of the reaction 
product (purple coloured complex). The amount of purple colour produced (BCA/Cu+ 
complex) or reduced Cu+2 is proportional to the amount of protein present in the 
solution (Olson and Markwell, 2007). 
 
Bovine serum albumin (BSA) standard curve samples (0.125, 0.25, 0.5, 0.75, 
1, 1.5 and 2 mg/mL) were prepared in RIPA per the manufacturer‘s instructions 
(Thermo Fisher Scientific, Loughborough, UK). Then, 5 µL of samples and standards 
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were added in duplicates into a 96-well plate. The blank used was RIPA buffer only. 
Then, 200 µL of mixture of Pierce™ BCA reagents A and B (Thermo Fisher 
Scientific, Loughborough, UK) at the ratio of 1:50, was added to each well containing 
standards, samples or blanks. The plate was then gently mixed for few seconds on a 
plate shaker. After incubation for 30 minutes at 37°C, a purple colour had developed 
in the wells. Then the amount of protein present in each well was quantified by 
measuring the absorption spectrum at 540 nm within one hour of incubation and by 
comparing with known concentrations of the BSA standard curve. Briefly, a standard 
curve was constructed using Microsoft Excell and the protein concentrations were 
calculated using the standard curve obtained. The desired coefficient of 
determination (R2) was always over 0.96.  
 
2.7.3. Sample preparation and protein denaturation for electrophoresis. 
 
Protein samples were prepared for gel electrophoresis by mixing them in a 1:1 ratio 
with loading buffer containing 250 mM Tris-HCl pH 6.8, 10% sodium dodecyl sulfate 
(SDS), 50% glycerol and 0.025% bromophenol blue. SDS is an anionic detergent 
which denatures secondary and non–disulphide–linked tertiary structures, and 
applies a negative charge to each protein in proportion to its mass. Glycerol is added 
to increase the density of the samples to layer the samples at the bottom of the gels, 
and 50% bromophenol blue is a tracking dye to monitor protein migration. Then 
samples were heated to 95°C (6 minutes) in a heating block to further promote 
protein denaturation and help SDS to bind. Samples were then processed for 
western blotting or stored at -20°C until further analysis.  
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2.7.4. Western blotting analysis. 
 
After protein concentration and sample preparation as previously outlined, equivalent 
amounts of protein (20-25 μg) per sample were resolved by SDS-polyacrylamide 
gels (4-12%) (Sigma-Aldrich, Gillingham UK) for 1 hour 30 minutes at 100 volts in a 
TruPAGE™ TEA-Tricine SDS running buffer (Sigma-Aldrich, Gillingham UK) and 
transferred to a Immobilon-FL polyvinylidene difluoride (PVDF) transfer membrane 
(Merk Millipore®, Tullagreen, Germany) pre-soaked in methanol to activate the 
membrane. A wet transfer method was used to transfer proteins form the gel to the 
PVDF membrane for 2 hours at 70 volts or at 35 volts overnight (16 hours) at 4ºC in 
a NuPAGE® transfer buffer (Novex by Life Technologies, USA). The membranes 
were then blocked in Tris-buffered saline (TBS) containing 0.1% Tween 20 (TBS-T) 
and 0.1% (w/v) non-fat dry milk at room temperature with regular shaking for 1 hour. 
Blot membranes were washed four times with TBS-T, 10 minutes for each wash. 
Membranes were then incubated overnight at 4°C with regular shaking with the 
appropriate dilution of the following primary antibodies: polyclonal rabbit anti-BiP at 
1:500 dilution, monoclonal rabbit anti-phospho-eIF2α (S473) at 1:1,000 dilution, 
polyclonal rabbit anti- eIF2α at 1:1000, monoclonal mouse anti-eNOS antibody at 
1:300 dilution, polyclonal rabbit anti-caveolin-1 at 1:300 dilution, monoclonal rabbit 
anti-phospho-eNOS at 1:500 dilution, mouse, polyclonal rabbit anti-VIMP (SelS) at 
1:500 (Cell Signalling Technology, Boston, USA) and mouse anti-β-actin diluted at 
1:5,000 (Santa Cruz, UK) were used as a loading controls. All primary antibodies 
recognize human proteins.  
The membranes were then washed at least three times for 10 minutes per 
wash in TBS-T and incubated for 1 hour at room temperature with the appropriate 
fluorophore conjugated goat anti-mouse or goat anti-rabbit antibodies 1:1,5000 
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(LICOR, UK). Immuno-reactivity was visualized with fluorophore conjugated 
secondary antibodies were detected immediately after washing with ODYSSEY®CLx 
infrared imaging system scanner (LI-COR Biotechnology - UK Ltd, Cambridge, UK). 
Each experiment was repeated at least three times.  
2.8. Measurement of apoptosis using flow cytometry 
 
Apoptosis was measured using ApoScreen® Annexin V Apoptosis Kit 
(SouthrenBiotech, LifeTechnologies, UK). The ApoScreen® Annexin V Apoptosis Kit 
employs an R-phycoerythrin-labelled Annexin V (Annexin V-PE) in concert with 7- 
amino actinomycin dye (7-AAD) to evaluate sub-populations of cells undergoing 
apoptosis. During the early stages of apoptosis, cells begin to display the inner 
phospholipid membrane component called phosphatidylserine (PS) on the outer cell 
membrane. PS becomes readily detectable by staining the cells with Annexin V-PE. 
As the plasma membrane becomes increasingly permeable during the later stages of 
apoptosis, 7-AAD can readily move across the cell membrane and bind to cellular 
DNA, providing means for identifying those cells that have lost membrane integrity 
through mechanisms including necrosis. When cells are double stained with Annexin 
V-PE and 7-AAD, four different cell populations may be observed as shown in Figure 
2.1: unstained cells, cells stained with Annexin-V or 7-ADD only, and cells that are 
stained with both Annexin V and 7-ADD dyes. 
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Figure 2.1. FACS analyses of the apoptotic cells. PE represents the detector for 
the Annexin V and PerCPcy5-5 represent the detector for 7-AAD dye. Q1 is for 
necrosis, Q3 is the negative live cells and Q2 and Q4 are apoptotic cells. 
 
EA.hy926 cells were plated in 6-well plates and after reaching 70-80% 
confluence, were treated with various concentrations of sodium selenite for 24 hours 
in the presence or absence of PBA (Sigma-Aldrich, Gillingham, UK). Cells were then 
detached with trypsin and centrifuged. PBA is a chemical chaperone that inhibits ER 
stress by stabilising protein conformation in the ER (Ozcan et al., 2006 ).  Medium 
was discarded and the pellet was washed twice with PBS. Cells were then re-
suspended in cold 1X binding buffer at the concentration of 106 to 107 cells/mL. Then 
100 µL of cell suspension was added to one Falcon tube for each sample. Cells and 
controls were incubated with 10 µL of Annexin V-PE dye for 15 minutes on ice, 
protected from light, followed by addition of 380 µL of 1X binding buffer and 10 µL of 
7-ADD dye. Samples were then immediately analysed by FACS Canto II and data 
captured and analysed.  
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Compensation set up was performed before each experiment to assure the 
accuracy and the quality of the results and to discriminate ‗spillover‘ of 7–ADD 
fluorescence on the background of the Annexin V fluorescence. Four tubes were set 
up as follows: 
Tube 1: No stain 
Tube 2: 7-ADD dye 
Tube 3: Annexin V dye 
Tube 4: Both 7-ADD and Annexin-V dyes. 
Samples were analysed, compensation was performed and targeted at less 
than 40% of the ‗spillover‘ of each dye into the other dye (PE-%PerCy5-5=20% and 
PerCy5-5-%PE= 39%). 
 
2.9. Caspases 3/7 activity 
 
Caspases 3/7 activity was measured using Caspase-Glo® 3/7 Assay (Promega 
Corporation, Madison, USA). Caspase-Glo® 3/7 reagent contains a pro-luciferin 
attached to Z-DEVD-amino-luciferin, which is an alternative substrate for luciferase 
and specific for protease cleavage by caspase-3 and caspases-7. Caspase-3/7 
cleaves DEVD (Benzyloxycarbonyl-Asp (OMe)-Glu (OMe)-Val-Asp (OMe) just after 
the second aspartic acid residue (D), and the resulting aminoluciferin. Aminoluciferin 
is a luminescent substrate for the luciferase reaction. The light output from the 
luciferase reaction is directly proportional to the activity of the caspases enzyme. 
 
EA.hy926 cells were grown in a 96-well white-walled plates at the density of 
10,000 cells per well in 100 μL of DMEM media constituted with 10% FBS, 1% 
penicillin/Streptomycin and 1% NEAA. Cells were incubated at 37°C in 5% CO2 and 
incubated at 95% humidity for 24 hours before treatments. Thereafter, cells were 
treated with varying concentrations of sodium selenite, as stipulated before, or 1mM 
Page 74 of 167 
 
of staurosporine in the presence or absence of  20 mM of PBA and 50 µM of 
Caspase® 3/7 inhibitor in serum, antibiotics and NEAA-free medium for either 8 or 
24 hours. Culture Plates were left to equilibrate at room temperature for 15 minutes 
and 100 µL of Caspase-Glo® 3/7 Reagent (Promega Corporations, Madison, USA) 
was added to each well. The mixture was mixed by using a plate shaker at 400 rpm 
for 30 seconds and left in the dark at room temperature for 2 hours. The activity of 
caspase 3/7 was then measured using a luminometer. The optical densities were 
subtracted from the blank and the activity was plotted as a percentage and analysed 
using one way-ANOVA using Graph Pad Prism version 7 software.  
2.10. Measurement of reactive oxygen species 
 
Reactive oxygen species such as H2O2, peroxynitrite (ONOO
-), hydroxyl radicals 
(OH), hydroperoxyl radicals (HOO), superoxide (O2
–) and oxygen radicals are 
produced in cells and the accumulation of intracellular ROS contributes to insulin 
resistance and endothelial dysfunction. Dihydroethidium (DHE) dye is specifically 
oxidised by O2
–, the main ROS in the vasculature, and the oxidized dye intercalates 
with nuclear DNA to fluoresce a red colour. The fluorescence intensity in the nucleus 
is proportional to the amount of O2
– present in the cell (Uy, McGlashan and Shaikh, 
2011). 
 
EA.hy926 cells were plated at the density of 200,000 cells per well and left to 
grow to 60-70% of confluency. Twenty-four hours later, sodium selenite prepared in 
PBS was added to the media at the concentrations of 0.5, 5, 10 and 20 µM and 
incubated for 8 hours at 37°C, 95% humidity and 5% CO2. We have used H2O2 at the 
concentration of 100 μM incubated for 45 minutes as a positive control. After 
treatments, medium was transferred into 15 mL tubes. Cells were detached with 
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trypsin-EDTA for 2-3 minutes at 37°C, 95% humidity and 5% CO2 and trypsin 
deactivated with 2 mL of complete medium. Cells were then transferred into 15 mL 
tubes containing the medium followed by centrifugation at 500 g for 10 minutes. The 
pellet was washed twice with PBS. Cells were then re-suspended in 1 mL of PBS 
and mixed with DHE at a final concentration of 10 µM. Cells were left for staining for 
30 minutes in the incubator at 37°C, 95% humidity and 5% CO2. ROS were then 
measured by flow cytometry using FACS CANTO II (BD Bioscience, UK). Negative 
and positive cells were plotted using the positive sample and DHE negative cells 
(P2) were separated from the positive cells (P3). All cells in the P3 channel were 
considered positive for DHE as shown in Figure 2.2. Cells positive for DHE were 
plotted in the graph pad and samples compared to the negative control. 
 
Figure 2.2. FACS gate discriminating DHE positives from DHE negative cells. 
EA.hy926 cells treated with 100 μM of H2O2 to discriminate DHE positive cells from 
the DHE negative cells. DHE negative cells were captured in the P2 channel and the 
DHE positive cells were collected in the P3 channel.  
 
2.11. Nitric Oxide (NO) measurement: Griess assay 
 
Nitric Oxide (NO) is rapidly oxidized to nitrite and/or nitrate by oxygen therefore NO 
produced can be estimated by determining the concentration of nitrite and nitrate 
end-products in biological systems. The Griess test was used to measure the 
concentration of nitrite as an indirect way of estimating the levels of NO. In this 
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method, the Griess reagent kit (Molecular Probes, Life Technologies, UK) was used 
following the manufacturer‘s protocol.  
 
HUVECs cells were plated in 96-well plates at a density of 10,000 cells per 
well and left to attach for 24 hours. Then, cells were treated with 0.5, 5, 10 and 20 
µM sodium selenite in the presence or absence of 20 mM of PBA for 24 hours. For 
treatments in the presence of PBA, cells were pre-treated with PBA for 12-14 hours 
before addition of selenite. Standards were prepared from a manufacturer‘s stock 
100 µM of nitrite in 1:2 serial dilutions with the lowest concentration being 1.56 µM of 
nitrite. Samples were then allowed to react with 20 µL of 1:1 of sulphanilamide (SA): 
N-naphthyl-ethylenediamine (NED). The samples and standards were then topped 
up to 300 µL with deionized water and incubated for 30 minutes at room 
temperature. SA was dissolved in 5% phosphoric acid to react with nitrite and/or 
nitrate to form a transient diazonium salt and NED, followed by a, a stable azo 
compound. Spectrophotometric absorbance was measured at 540 nm using a multi-
plate reader. The intensity of the azo dye is directly proportional to the amount of 
nitrite/nitrate in the sample which is also proportional to the amount of NO produced. 
 
2.12. In vitro tube-like structure formation assay on Matrigel® matrix 
 
HUVECs were seeded into 6-well plates at the density of 200,000 cells/well 
overnight followed by treatment with 0.5, 5 and 10 µM of sodium selenite for 24 
hours in the absence or presences of PBA (Sigma, Gillingham, UK) or PERK 
Inhibitor I, GSK2606414 (Calbiochem®, Millipore, USA). Then, cells were seeded 
(100 000 cells per well) on 24-well culture plates coated with a basement membrane 
preparation extracted from  Engelbreth-Holm-Swarm murine sarcoma (Matrigel®; BD 
Bioscience, Oxford, UK). To perform the experiment, 250 µL of Matrigel® substrate 
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diluted with serum-free medium (1∶1 dilution) was added into each well of 24-well 
plates and allowed to solidify for 1 hour at 37°C. While the Matrigel®; was solidifying, 
cells were washed with 1 mL of PBS twice, trypsinised and centrifuged to collect 
cells in a 15 mL tube. Supernatant was discarded then, cells were mixed with M200 
medium supplemented with LSGS and plated on coated 24 well plates. Untreated 
cells cultured in M200 medium without LSGS were used as the negative control. 
HUVECs were incubated for further 6 hours and tube-like structures formation was 
examined using an inverted phase contrast microscope. Then, using ImageJ 
software, the number of tubes formed (Mesh) were counted in 5 different blind fields, 
averaged then compared across the different samples. Experiments were performed 
in triplicates. 
 
2.13. Statistical Analysis 
 
Statistical analysis was performed using GraphPad Prism® version 7 software using 
both one-way Analysis of Variance (ANOVA) and two-way ANOVA. A p-value of less 
than 0.05 was considered as statistically significant between the control and the 
different concentrations of sodium selenite. Results were expressed as mean, 
standard error of the mean (SEM). Dunnett‘s and Tukey‘s multiple comparison test 
(post hoc test) were performed from data showing statistically significant results in 
one-way ANOVA whereas Bonferroni‘s post-hoc test was performed from data 
showing statistically significant results in two-way ANOVA.  
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Chapter 3. Results 
High selenium treatment activates the ER 
stress response in cultured endothelial 
cells and hepatocytes. 
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3.1 Introduction 
 
Se is an essential trace element in human health (Rayman, 2012). Se concentration 
has a ―U‖ shaped relationship to human disease, meaning that both very high 
plasma Se concentrations (>2M or >300 g/day of Se) and Se deficient status (< 
0.5 M/ 60 g/day of Se) are associated with an increased risk of diseases such as 
type 2 diabetes and CVD (Stranges et al. 2010). Most of the Se supplements for 
human and animal consumption contain the inorganic form of Se, selenite (Rayman, 
Infante and Sargent, 2008; Burk and Hill, 2015). Selenite has been well investigated 
due to its anti-oxidant activity as it is plays a role in cellular redox homeostasis 
(Rayman, 2012; Burk and Hill, 2015).  Se is available in both organic and inorganic 
forms; inorganic forms of Se include, selenite and selenate, while the organic forms 
are mainly found in nutritional supplements such as SelMet, MSA and 
selenocysteine (Burk and Hill, 2015). It has been previously shown that selenite is 
more toxic to cells than selenate (Brasher and Scott Ogle, 1993; Abdo, 1994; Burk 
and Hill, 2015). However, once absorbed by the cells, selenate is completely 
converted to selenite which is then converted to methylselenol, the active form of Se 
(Burk and Hill, 2015). Methylselenol is used in the biosynthesis of selenocysteine 
(Burk and Hill, 2015), the 21st amino acid needed for the synthesis and function of 
selenoproteins.  
 
High Se concentrations were shown to induce cell death in prostate cancer 
cells and it was postulated that this Se-induced cytotoxicity was mediated through 
the induction of a newly recognised metabolic pathway called endoplasmic reticulum 
(ER) stress (Wu et al., 2005). Using PC3 human prostate cancer cells, Wu and co-
workers (2005) showed that several ER stress markers such as binding 
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immunoglobulin protein also known as glucose regulated protein 78 (BiP/GRP78), 
phosphorylated protein kinase RNA-like ER kinase (phospho-PERK), 
phosphorylated eukaryotic initiation factor-2 alpha (phospho-eIF2) and 
CAAA/EBPα-homologous protein (CHOP) were induced by treatment with 
methylseleninic acid (MSA), a source of Se. Of relevance, the levels of CHOP, a pro-
apoptotic transcription factor normally induced during ER stress (Wang and 
Kaufman, 2016) were elevated after a 24 hour MSA treatment and this increase was 
accompanied by increases in the levels of additional  apoptotic markers such as 
caspase 7, caspase 2 and cleaved PARP. Thus, at least in prostate cancer cells, ER 
stress seems to mediate Se induced cell death (Wu et al., 2005). Furthermore, high 
selenite concentration, 20 µM, has been shown to induce apoptosis through 
activation of ER stress in a time dependant manner in NB4 cells, a type of human 
acute promyelocytic leukemia cells (Guan et al., 2009).  
 
In recent years, several studies have shown an association between high Se 
intake and the activation of ER stress (Wu et al., 2005; Zu et al., 2006; Hwang et al., 
2007). Interestingly, ER stress has also been shown to be activated in animal 
models of obesity and diabetes and to be implicated in impairing the insulin 
signalling pathway and causing hepatic insulin resistance (Ozcan et al., 2004). 
Overexpression of ER stress markers has been observed in liver and adipose tissue 
from obese and diabetic animals and in humans (Hotamisligil, 2010; Hummasti and 
Hotamisligil, 2010). Furthermore, ER stress has also been reported to play a key role 
in the development of endothelial dysfunction in animal models of diabetes and 
atherosclerosis (Kassan et al., 2012). However, the role of ER stress in insulin 
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resistance or endothelial dysfunction mediated by high Se has never been 
investigated.  
3.2 Results 
3.2.1 High Selenium treatments cause ER stress induction in hepatocytes 
 
Previous studies have shown that high ER stress leads to hepatic insulin resistance 
(Ozcan et al., 2004). Furthermore, high Se was shown to impair hepatic insulin 
sensitivity in rat normal hepatocytes cell line BRL-3A (Zeng et al., 2012). Human 
cancer studies suggested that high Se intake leads to impaired insulin sensitivity 
therefore leading to increased risk of type 2 diabetes (Laclaustra et al., 2010). To 
address the impact of high Se concentrations on ER stress activation, the effect of 
Se on the activation of ER stress response was assessed in cultured cells 
hepatocytes, HuH-7 cells and HepG2 cells and endothelial cells EA.hy926 cells and 
Human Umbilical Vein Endothelial cells (HUVECs). ER stress was assessed by 
assessing the phosphorylation levels of eIF2-α, an ER stress marker activated upon 
auto phosphorylation of protein kinase RNA-like ER kinase (PERK) in order to 
attenuate further protein translation and at the same time selectively stimulate 
translation of Activating translating factor 4 (ATF-4) to increase the stimulation of the 
unfolded protein response target genes to alleviate ER stress (Wang and Kaufman, 
2016). 
  
Our results show that Se in the form of selenite induces ER stress in a time 
and dose dependent manner. Figure 3.1 shows that eIF2-α phosphorylation 
increased 30 minutes after selenite treatment, at both 10 and 30 µM concentrations, 
and peaked at 1 hour, remaining stable up to 12 hours after treatment (Figure 3.1D). 
Interestingly, cells treated with physiological concentrations of selenite (0.5 µM) 
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showed phosphorylation of eIF2 as early as 30 minutes and remained constant for 
24 hours, however high concentrations of selenite (30 µM) showed the level of 
phosphorylation to decline after 8 hours (Figure 3.1C) compared to 10 µM treated 
cells which phosphorylation of eIF2a peaked from 1 hour and remained constant for 
24 hours as shown in Figure 3.1B. The enhanced phosphorylation of eIF2-α 
indicates the activation of the PERK/ eIF2-α arm of the ER stress response.  
 
 
Figure 3.1. High Se treatments enhance phosphorylation of eIF2-α on serine 51 active 
site (S51). Phosphorylation of eIF2-α in HuH 7 cells treated with sodium selenite at the 
concentrations of 0.5 μM (A), 10 μM (B) and 30 μM (C) at the indicated time points. GAPDH 
is a loading control. These are representative figures of two independent experiments.  
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To further assess the activation of ER stress response in these cells, we also 
investigated the expression of another key ER stress marker, CHOP. As a positive 
control for ER stress induction, HuH-7 cells were treated with tunicamycin, a general 
glycosylation inhibitor that is known to be as a powerful pharmacological inducer of 
ER stress, besides treatment with selenite. As shown in Figure 3.2, the treatment of 
cells with both tunicamycin and selenite enhanced CHOP expression, indicating the 
activation of ER stress response. CHOP expression in HuH-7 cells peaked at 3 
hours and declined after 8 hours in cells treated with high selenite concentrations, 
30µM.  
 
 
Figure 3.2. High Se treatments activation of CHOP. Expression of CHOP protein in HuH-
7 cells treated with either tunicamycin (Tun, 5 μg/mL for 2h) or sodium selenite at the 
concentrations of 30 μM at the indicated time points. This is a representative figure of two 
independent experiments. 
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In addition to Huh7 cells, the effect of high Se was also investigated in HepG2 
cells. This time, ER stress induction was examined by qPCR to assess the 
transcriptional up-regulation of known ER stress effector proteins. mRNA expression 
of BiP, ATF-4 and CHOP was assessed. Figure 3.3A-B shows that there was no 
significant activation of the ER stress markers BiP and CHOP in hepatocytes 8 hour 
post-selenite treatment (p<0.05), however there is a positive trend associating high 
BiP and CHOP expression with increasing concentrations of selenite in HepG2 cells 
(Figure 3.3A-B). Nonetheless, ATF4 mRNA expression was significantly increased 
compared to untreated (CTL) samples (2.7-fold, p<0.001) in HepG2 cells treated with 
supraphysiological selenite concentrations (10 µM) compared to physiological 
concentrations (0.5 µM). 
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Figure 3.3. High Se treatment induces ER stress in hepatocytes. mRNA expression of 
BiP (A), CHOP (B)  and ATF4 (C) at 8 hours post selenite stimulation. Relative mRNA 
expression was normalised to a housekeeping gene expression (β-actin) and fold change 
was determined relative to the control sample, which is the untreated sample. High selenite 
concentrations, 5 and 10 µM, did not significantly induces ER stress markers BiP (A) and 
CHOP (B), however there is a trend showing higher BiP and CHOP expression as selenite 
concentrations increase. Treatment of hepatocytes with 10 µM of selenite significantly 
increased ATF4 (C) mRNA expression at 8 hours post selenite treatment (2.7 fold increase 
p<0.001).  Data are presented as mean ± SEM and were analysed using one-way ANOVA 
followed by Dunnett‘s post-hoc test. *P< 0.001 vs. CTL. N = 3 independent experiments.  
Thapsigargin (300 nM) for 8 hours was used as a positive control.  
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 3.2.2 High selenium treatment activates the ER stress response in a time- and 
dose- dependent manner in endothelial cells 
 
Several studies have shown that high Se impairs insulin signalling and results in 
insulin resistance and hence increase the risk of type 2 diabetes in both animal and 
human studies (Bleys, Navas-Acien and Guallar, 2007; Steinbrenner, 2013). Insulin 
resistance is intimately associated with endothelial dysfunction, however the 
mechanism by which high Se induces endothelial dysfunction is yet to be elucidated. 
Therefore, we investigated the impact of high Se treatment in endothelial dysfunction 
by looking at ER stress activation in cultured endothelial cells.   To investigate the 
effect of high versus low concentrations of Se on ER stress induction in endothelial 
cells, HUVECs cells were treated with different concentrations of sodium selenite 
ranging from physiological levels, or 0.5 μM to the supra-physiological 
concentrations of 10 μM. Then mRNA expression of key ER stress genes were 
analysed by qPCR (BIP, CHOP and ATF4). As shown on Figure 3.4, a physiological 
dose of selenite (0.5 μM) did not affect the mRNA expression of any of the ER stress 
markers investigated at any of the three time points. However, higher selenite 
concentrations (5 and 10 μM) led to a significant increase in CHOP and ATF4 mRNA 
expression at all three times points, while BIP mRNA expression was only increased 
24 hours post-selenite treatment (Figure3.4B-C). 
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Figure 3.4. High Se induces ER stress in endothelial cells. mRNA expression of BiP (A), 
ATF4 (B)  and CHOP (C) at 4 hours, 8 hours and 24 hours post selenite treatment. Relative 
mRNA expression was normalised to a housekeeping gene expression (β-actin) and fold 
change was determined relative to the control sample that is an untreated sample. High 
selenite concentrations induces ER stress markers BiP (A), ATF4 (B) and CHOP (C) with a 
significant increase at 24 hours post selenite treatment (p<0.05). Data are presented as 
mean ± SEM and were analysed using two-way ANOVA followed by Bonferroni‘s post-hoc 
test. *P< 0.05 vs. CTL. N = 3 independent experiments. 
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3.2.3 High Selenium treatments cause ER stress induction in endothelial cells 
 
We next assessed eIF2-α phosphorylation after selenite treatment in endothelial 
cells. Once again, sodium selenite concentrations ranged from normal to supra-
physiological concentrations (0.5, 5, and 10 µM). As shown in Figure 3.5, sodium 
selenite treatment at low physiological concentration revealed low fluorescent signal 
indicating that 0.5M did not affect the phosphorylation of eIF2-α on serine 51 
throughout the period of incubation. Interestingly, however, higher concentrations of 
selenite at 5 and 10 µM induced eIF2-α phosphorylation as Figure 3.5 shows that 
higher concentrations of selenite produced intense signal on the western blot . 
Moreover, incubating HUVEC cells for 24 hours with physiological concentrations 
(0.5 µM) of selenite also does not increase BiP levels. Nonetheless, high Se 
concentration, 5 and 10 µM, increased expression of BiP. Figure 3.5 shows that 
sodium selenite not only induces ER stress in endothelial cells but also induces ER 
stress in a dose-dependent manner. Thapsigargin was used as a positive control for 
ER stress induction. 
 
 
Figure 3.5. High Se treatment enhances activation of BiP and phosphorylation of eIF2-
α at serine 51. Sodium selenite induced phosphorylation of eIF2-α and BiP in HUVECs cells 
treated with sodium selenite at the concentrations of 0.5 μM, 5 μM and 10 μM. -Actin is a 
loading control. This is representative figure of two independent experiments.   
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3.2.4 High selenium activates spliced XBP-1 in endothelial cells 
 
To validate the induction of ER stress by sodium selenite, XBP-1 splicing was 
investigated. Under conditions of stress, the activation of IRE1α, triggers an 
endoribonuclease activity that selectively cleaves a 26-nucleotide segment from 
XBP1 mRNA into spliced XBP-1 mRNA and unspliced form. The spliced XBP-1 
mRNA introduces a translational frameshift that creates transcriptionally active XBP-
1 (XBP-1s) to enhance protein folding and at the same time promote Endoplasmic 
reticulum-associated protein degradation (ERAD) pathway to resolve chronic ER 
stress through cell death. Figure 3.6 shows that unlike physiological concentration of 
selenite (0.5 µM), high selenite concentrations, 5 and 10 µM, activated the splicing of 
XBP-1 mRNA. The results shows that high Se in form of selenite induces ER stress 
in endothelial cells.  
 
Chemical chaperones, such as PBA, are thought to protect cells against ER 
stress by mechanisms that are not completely clear (Ozcan et al., 2006; Kim et al., 
2013). We wanted to investigate whether the use of a chemical chaperone could 
decrease ER stress in our system. Since PBA is a known chemical chaperone that 
prevents ER stress activation, we expected to see un-spliced XBP-1 only in the 
presence of PBA. However, PBA treatment resulted in XBP-1 splicing in the 
presence of selenite treatment indicating that PBA activates ER stress in the 
presence of selenite in endothelial cells, as shown in Figure 3.6.  
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Figure 3.6. High Se treatment activates splicing of the XBP-1 mRNA. High Se 
concentrations (5 µM and 10 µM) lead to XBP-1 splicing unlike the physiological 
concentration (0.5 µM). This is a representative figure of three independent experiments. 
 
3.2.5 Effects of high selenium on viability of endothelial cells and hepatocytes. 
 
Induction of ER stress is reported to be associated with cell death and therefore, we 
investigated the effect of ER-stress induction by high Se treatments on cell viability in 
both endothelial cells and hepatocytes. EA.hy926 endothelial cells were treated with 
varying concentrations of both inorganic (selenite, selenate) and organic (seleno-
methionine, SelMet) sources of Se while hepatocytes (HuH-7) were only treated with 
different concentrations of selenite. Then, cell viability was assessed using the MTT 
assay. As shown in Figure 3.7, the impact of Se on cell viability has proven to be 
dose dependant, cell specific and driven by the type of Se. Endothelial cells, 
EA.hy926, show to be more sensitive to selenite, than selenate and less sensitive to 
SelMet. Figure 3.7A shows that higher selenite concentration, 10 µM, reduces 
EA.hy926 viability to 42% (p<0.0001) compared to control (CTL) and to treatment 
with a low 0.5 µM dose. Interestingly, another high concentration, 5 M 
concentration, of selenite (Figure 3.7A), selenate (Figure 3.7B), and SelMet (Figure 
3.7C), did not significantly reduce viability of EA.hy926 cells. Importantly, more 
selenate (100 M) compared to 10 µM  of selenite was required to significantly 
reduce EA.hy926 cell viability to 49% (p<0.001).  
 
 
XBP1s 
XBP1u 
Thaps 0 μM 0.5 μM 5 μM 10 μM 
+PBA 
0 μM 0.5 μM 5 μM 10 μM 
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Concentrations of Se considered to be high (5-10 µM) did not significantly 
reduce hepatocytes cell viability in all three forms of Se.  Interestingly, the organic 
form of Se, SelMet, and inorganic form of Se, selenate, did not affect hepatocyte 
viability at concentrations up to 100 M , as shown on Figure 3.7F and Figure 3.7E, 
respectively. Additionally, varying concentrations of selenite (0.5 M- 10 M) 
treatment did not affect HuH-7 cell viability (Figure 3.7G). On the other hand, 
supranutritional concentrations of selenite (of more than 20 M) of selenite 
negatively affected hepatocytes, significantly reducing HepG2 cells viability to 65%-
10% (p<0.001) in a concentrations dependent manner (Figure 3.7D). 
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Figure 3.7. Effects of high Se on viability of endothelial cells and hepatocytes. Cell 
viability of EA.hy926 endothelial cells treated with different concentrations of sodium selenite 
(A), selenate (B) and SelMet (C). Cell viability of HepG2 treated with varying concentrations 
of selenite (D), selenate (E) and SelMet (F). HuH-7 hepatocytes treated with various 
concentrations of sodium selenite (G).  Relative cell viability was expressed as a percentage 
(%) relative to the untreated control cells (NC). Data are presented as mean ± SEM and 
were analysed using one-way ANOVA followed by Dunnett‘s multiple post-hoc test. Se 
treatments were compared to CTL.  ***P<0.001, ****P<0.0001 vs. CTL. N = 4 (A-G).  
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3.3 Discussion 
 
Previous studies have shown that high Se concentrations induce ER stress response 
in different cell lines such as human promyelocytic leukaemia cells, prostate cancer 
cells, adipocytes, human neurons, HeLa cells and pancreatic β-cell (Wu et al., 2005; 
Zu et al., 2006; Hwang et al., 2007; Wallenberg et al., 2014). Some of these studies 
have shown that Se causes ER stress in a dose- and time-dependent fashion (Zu et 
al., 2006; Guan et al., 2009). The present study extends the published findings and 
provides further evidence to support the role of high Se concentrations in activating 
ER stress in cultured endothelial cells. Our work shows that treatment with Se in the 
form of selenite induces a number of ER stress markers in a time- and dose-
dependent manner both at the mRNA and protein levels in endothelial cells. To the 
best of our knowledge, these findings are novel and have not been reported by other 
groups in endothelial cells.  
 
Chronic activation of the UPR activates the expression of the pro-apoptotic 
protein CAAA/EBPα-homologous protein (CHOP) which is positively controlled by 
the PERK-ATF4 axis of the UPR (Schröder and Kaufman, 2005; Hetz, 2012). CHOP 
is a transcription factor which in turn promotes the transcription of growth arrest 
genes such as Bcl-2 Interacting mediator (BIM) proteins and the BH3 class family to 
result in apoptosis (Flamment et al., 2012; Inagi, Ishimoto and Nangaku, 2014). 
Therefore, due to the potential of chronic ER stress to induce cell death, the effects 
of high Se on cell viability were first investigated. At concentrations of Se that we find 
induce markers of ER stress, we see no evidence of compromised viability, at least 
in hepatocytes (HuH-7 and HepG2) at the time point examined (24h). Conversely, 
endothelial cells were found to be more sensitive to selenite; 10 µM of sodium 
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selenite significantly reduced cell viability in endothelial cells compared to 
hepatocytes 
Genetic differences between cell lines studied could contribute to the 
differences in sensitivity to Se we observed. For example, it has already been 
established that HuH-7 cell lines are Trp53 mutant (Hsu et al., 1993). Trp53 (or 
transformation related protein 53) is a gene coding for a tumour suppressor 
transcription factor, p53, that is pivotal for cell cycle control and apoptosis induction 
in response to DNA damage treatments and other insults such as hypoxia and 
telomere shortening (Pietsch, Humbey and Murphy, 2006). The mechanism by which 
p53 induces apoptosis are more complex; it can stimulate many pro-apoptotic genes 
as well as bind and inactivate anti-apoptotic Bcl-2 protein to promote apoptosis. p53 
mutant cells tend to escape apoptosis; DNA  damaged cells may continue dividing 
without pausing for DNA repairing process resulting in uncontrolled cell division and 
cell growth hence making cells cancerous and  resistant to anti-cancer drugs and 
irradiation in some tumour cells (Brosh and Rotter, 2009; Amaral et al., 2010).  
 
Our results in Figure 3.7G shows that 10µM of selenite did not reduced HuH-7 
viability, a Trp53 mutant cell line with p53 mutation, unlike in HepG2 and EA.hy926 
cells (Figure 3.7A and 3.7D); both known to have wild type p53 and therefore normal 
levels of p53 protein (Kao et al., 2004; Yang et al., 2007). The results showed that 
endothelial cells) are more sensitive to high Se in the form of selenite than HepG2 
cells which are also more sensitive to selenite treatment than HuH-7 cells. Figure 3.7 
A, D and G plainly show that 10 µM of selenite significantly reduced endothelial cell 
viability compared to both hepatocytes cell lines.  Moreover, comparing 5, and 10 µM 
of all the Se forms used, selenite ( vs selenate and SelMet) appeared to negatively 
affect cell viability of endothelial cells more than HepG2 cells and HuH-7 cell lines.  
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Se is known to cause cell death and DNA damage in animal and human cell 
culture at high concentrations attracting a considerable attention as a possible anti-
cancer agent (Duffield-Lillico et al., 2003; Wu et al., 2005; Guan et al., 2009). 
Therefore, it is not surprising to find that 5 µM and 10 µM concentrations 5 and 10 
µM) of selenite caused cell death, as shown in Figure 3.7A, as these are the same 
concentrations that induces ER stress mechanism in endothelial cells (Figures 3.5 
and 3.6). It has been established that high Se supplementation leads to ER stress 
induction and cell death in cancer and prostate cancer (Wu et al., 2005; Zu et al., 
2006; Hwang et al., 2007; Wallenberg et al., 2014), in addition chronic ER stress is 
known to activate the apoptosis pathway through the activation of a pro-apoptotic 
marker CHOP (Oyadomari and Mori, 2004; Hetz, 2012). We therefore report that 
high Se concentration not only leads to ER stress induction in human endothelial 
cells but also reduced endothelial cell viability as shown in Figures 3.5-3.7A. Figures 
3.7A and 3.7D show that endothelial cells and hepatocytes are more sensitive to 
selenite than other forms of Se (selenate and SelMet) used in the study. 
   
Although selenite reduced cell viability in hepatocytes at high concentration 
(higher than 20 µM), the concentrations above 20 µM are considered supranutritional 
concentrations and are not practical for human supplementations. Our results 
suggest that different cell cultures respond differently to the type of Se sources and 
the concentrations used in experiments. The physiological requirement for maximal 
selenoprotein function for human health and protection against some cancers is 45-
120 µg/day which is equivalent to optimal physiological level of 0.5-2 µM in human 
plasma (Thomson, 2004) and the concentrations used (0, 0.5, 5 and 10 µM) in the 
experiment fall within the acceptable range required for Se supplementation with 5  
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and 10 µM marked as tolerable  non-toxic high concentration for human consumption 
(Burk, 2002; Burk and Hill, 2015).  
 
Se is an element known for its anti-oxidant function (when present as 
selenoproteins) and its insulin-mimetic actions when taken at physiological and 
nutritional amounts (Stapleton et al., 1997). However, high supra-nutritional Se 
intake has been found to impair insulin sensitivity and therefore increase the risk of 
type 2 diabetes and be associated with endothelial dysfunction and CVD (Mueller et 
al., 2009; Saverio Stranges et al., 2010; Rayman, 2012; Chistiakov et al., 2014). 
Several in vivo and in vitro studies have shown that high Se intake is involved in 
impairing insulin signalling and linked to atherosclerosis and increased risk of CVD 
(Ozcan et al., 2004, 2006; Myoishi et al., 2007; Tabas, 2009); however, the 
underlying molecular mechanism(s) are yet to be elucidated. From cancer studies, it 
was observed that treatment of cancer cells with high amounts of Se leads to cell 
death through the activation of ER stress (Wu et al., 2005; Zu et al., 2006; Guan et 
al., 2009; Chistiakov et al., 2014). In comparison, our results showed that high Se 
(selenite) concentrations result in cell death; 39% (p=0.0122) of human endothelial 
cells were viable post 10 µM of selenite treatment. However, the mechanism(s) 
involved are yet not known.  We therefore selected 5 and 10 µM of selenite as a 
model for high Se supplementation and 0.5 µM as a physiological concentration to 
investigate the role of ER stress in high Se intake using human umbilical vein 
endothelial cells as model.  
 
ER stress has also been reported to be activated in various insulin-resistant 
states and was shown to contribute to insulin resistance and vascular dysfunction via 
the activation of complex inflammatory pathways (Araki, Oyadomari and Mori, 2003; 
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Hotamisligil, 2010; Agouni et al., 2011; Basha et al., 2012; Flamment et al., 2012). 
Therefore, we hypothesised that high Se intake would be associated with the 
activation of ER stress response in cultured endothelial cells leading to endothelial 
dysfunction, precursors of diabetes associated CVDs. Our results show that: (i) Se 
induces ER stress in a dose- and time-dependent manner in hepatocyte HuH-7 cells, 
measured as phosphorylation of eIF-2α and (ii) high selenite concentration activated 
the induction of CHOP in a time dependant manner. Taken together, our results are 
in agreement with Guan et al (2009), which showed that selenite induced ER stress 
in pro-myloecytic cells, in a time dependant manner (Guan et al., 2009).  
 
It must be noted that 30 µM of selenite is toxic to human consumption 
therefore 10 µM was the selected dose to represent high selenite concentration. 
Interestingly, treatment with 5 µM and 10 µM Se increased mRNA expression of ER 
stress markers, BiP and CHOP in HepG2 cells, but this increase was not statistically 
significant. Cell viability assay suggest that hepatocyte might  have a high threshold 
for selenite and other Se sources concentrations and therefore be a  robust cell 
model in Se induced ER stress studies perhaps due the fact that HepG2 cells 
express  p53 wild type and have well expressed p53 protein (Kao et al., 2004).   
 
Some recent studies have shown that ER stress activation in models of 
diabetes and hypertension is associated with endothelial dysfunction, the initial step 
for the development of atherosclerosis (Basha et al., 2012). Our data clearly shows 
that high Se intake leads to the activation of ER stress in endothelial cells. Our 
results suggest that Se in the form of selenite activates ER stress through the PERK 
arm of the unfolded protein response (UPR) mechanism. Disturbance in the normal 
function of the ER leads to accumulation of mis-folded proteins in the ER lumen 
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causing activation of the UPR to restore ER homeostasis. However, if the ER stress 
dysfunction persists, ER stress eventually causes cell death or apoptosis. There are 
three ER stress-sensing proteins (PERK, IREα and ATF6) on the ER lumen, all 
bound with the chaperone BiP and kept inactive through this interaction. During UPR 
activation, BiP dissociates from these three stress-sensing proteins to alleviate the 
stress by up-regulating the transcription and translation of UPR chaperones including 
BiP to correct the ER stress and dysfunction (Schröder and Kaufman, 2005; Hetz, 
2012).  
 
Se in the form of selenite has been demonstrated to induce necroptosis-like 
cell death in HeLa cells (Wallenberg et al., 2014). The former study also showed 
evidence of increased ER resident proteins, BiP and CHOP; indicating the induction 
of ER stress in HeLa cells with selenite treatment. Our results shows that high Se 
concentrations induced the activation of BiP protein in endothelial cells as well as the 
phosphorylation of eIF2α by western blot technique. Both qPCR and western blot 
technique shows that at 24 hours high Se induced transcription of ATF4 and CHOP 
and the same there is protein translation at 24 hours of ER stress markers (BiP and 
P-eIF2α), suggesting that ER transcription and translation of ER stress markers 
concurrently occurs in order to rescue the cells from dysfunction or attenuate the 
cells to preserve cell function and metabolism.  
 
Furthermore, high Se concentration leads to XBP-1 splicing in endothelial 
cells. Although pre-treating endothelial cells with a chemical chaperone, PBA, 
induced XBP-1 levels and splicing instead of inhibiting it as it would be expected for 
a chemical chaperone (Ozcan et al., 2006), we think this is due to the fact that PBA 
has been shown to have transcriptional up-regulating effect (Perlmutter, 2006). XBP-
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1 is a transcription factor activated by a non-canonical splicing reaction mediated by 
the endonuclease IRE1 ( Hetz, 2012). XBP-1 controls the expression of genes that 
encode for proteins involved in protein folding and endoplasmic-reticulum-associated 
protein degradation (ERAD) process and protein quality control mechanism (Hetz, 
2012), such as CHOP. Since high Se induced XBP-1 splicing, it is therefore not 
surprising that it also induced activation of CHOP protein in HuH-7 cells. In 
endothelial cells, moreover, there is a significant activation of CHOP mRNA after 
treatment with high Se concentrations.  
 
During ER stress, PERK dimerization followed by auto-phosphorylation leads 
to phosphorylation of eIF2α to attenuate further general protein synthesis except for 
the selective translation of the ATF4 mRNA. ATF4 mRNA is a transcription factor 
controlling the transcription of genes involved in the unfolded protein response for 
survival as well as in ERAD to correct the perpetuating ER dysfunction through 
apoptosis (Hetz, 2012). ATF4 transcription factor is thought to be activating XBP-1 
and CHOP, however XBP-1 is known to get spliced upon activation, dimerization and 
auto-phosphorylation of the IRE1α arm. It is therefore not clear which arm of the ER 
stress Se activates nevertheless it is evident that high Se induces ER stress in 
endothelial cells. 
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Chapter 4 Results 
High selenium treatment induces 
molecular changes in endothelial cells 
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4.1. Introduction 
 
The endothelium is composed of a monolayer of endothelial cells that line the entire 
innermost tunica intima of all vessels in the body. The primary function of the 
endothelium is to form a semipermeable membrane to retain the plasma and to aid 
the transfer of nutrients and white blood cells between tissues. It is recognised as 
being an endocrine organ able to sense mechanical and hormonal changes in the 
blood, but also to secrete various mediators and hormones (Rajendran et al., 2013). 
Endothelial cells regulate vascular homeostasis through the control of various 
vascular functions including angiogenesis, smooth muscle cell proliferation, 
migration of leukocytes and the maintenance of blood fluidity by balancing levels of 
pro- and anti-coagulants, growth factors, pro and anti-inflammatory molecules 
(Triggle and Ding, 2011). The endothelium senses shear stress produced by blood 
flow and responds to signals such as acetylcholine by secreting vasodilators namely 
nitric oxide, prostacyclin and vasoconstrictors such as endothelin to act on vascular 
smooth muscles to adjust for local blood flow (Davignon and Ganz, 2004).  Shear 
stress is a key activator of eNOS in normal physiology, and this adapts organ 
perfusion to changes in cardiac output. Dimmeler and colleagues has shown that 
activation of eNOS in endothelial cells is through the stimulation of 
phosphatidylinositol-4, 5-bisphosphate 3-kinase (PI(3)K/Akt) pathway (Dimmeler et 
al., 1999).  Shear stress in Human Umbilical Vein cells stimulates phosphorylation of 
the protein kinase B at serine 473 active site also known as Akt (Phospho-Akt 
ser473) on the serine residues of the active enzyme to enhance the phosphorylation 
of eNOS in order to activate production of NO (Dimmeler et al., 1999).  
 
  Nitric oxide (NO) is mainly generated from L-arginine from citruline by 
endothelial nitric oxide synthase (eNOS) in the presence of co-factors such as 
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tetrahydrobiopterin (BH4), NADPH and oxygen (Luiking, Engelen and Deutz, 2010). 
NO is rapidly converted to the NO metabolites nitrate and nitrite in less than one 
second in vivo, therefore nitrate and nitrites are used to measure the availability of 
NO to assess endothelial function (Dimmeler et al., 1999; Luiking, Engelen and 
Deutz, 2010). NO regulates blood flow, promote angiogenesis, inhibit thrombosis, 
maintain cellular redox state, cell immunity, and neuronal survival (Luiking, Engelen 
and Deutz, 2010).  NO is a main vasodilator, the gas diffuses to the vascular smooth 
muscle cells to activate guanylate cyclase, which leads to cGMP-mediated 
vasodilatation. In situation of hypoxia, low production of L-arginine and BH4, eNOS 
converts production of NO to superoxide (O2
–) by the endothelium and this is known 
as ―uncoupling‖ of eNOS (Deanfield, Halcox and Rabelink, 2007; Luiking, Engelen 
and Deutz, 2010). Uncoupled eNOs occurs mainly in pathological conditions such as 
hypertension, hypercholesterolemia and diabetes (Luiking, Engelen and Deutz, 
2010)  and this leads to increased production of reactive oxygen species (ROS) 
(Deanfield, Halcox and Rabelink, 2007). Increased ROS in form of superoxide reacts 
with available NO resulting in a by-product called peroxynitrite and this reaction 
activates inflammatory chemokines. Reduced bioavailability of NO through impaired 
production of NO leads to impaired vascular tone and activates inflammatory 
response therefore leading to endothelial dysfunction (Levick, 2003) (Bogdan, 2001; 
Hermann, Flammer and Lscher, 2006). 
 
Any disturbance in the function of the endothelial cells is referred to as 
endothelial dysfunction, a hallmark of CVD and a recognised early step in the 
development of atherosclerosis and coronary heart disease (Flammer et al., 2012). 
Endothelial dysfunction generally is defined as the imbalance between vasodilation 
and vasoconstriction with the balanced tipped towards vasoconstriction and 
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inflammatory response. Endothelial dysfunction contributes to vascular injury and 
damage which results in lipid deposition and oxidative stress within the vessel wall, 
triggering the activation of several inflammatory responses such as tumour necrosis 
factor (TNF)-α, c-Jun amino-terminal kinase (JNK) and Nuclear Factor (NF)-κB which 
can in turn worsen endothelial dysfunction (Libby, 2012).  
 
Whether ER stress plays a causative role in endothelial dysfunction remains 
to be established but it is important to mention that ER stress has been shown to be 
involved in the development of atherosclerosis (Erbay et al., 2009; Hotamisligil, 
2010; Flamment et al., 2012; Chistiakov et al., 2014). Expression of the ER stress 
markers, ATF4 and XBP-1, was increased in macrophages loaded with cholesterol 
(Li et al., 2005)  indicating that ER stress response is linked to the development of 
atherosclerosis and can increase the risk of CVD. Also, the ER stress markers 
CHOP and BIP were elevated in ruptured atherosclerotic plaques from human 
coronary artery autopsy samples (Myoishi et al., 2007). Macrophage apoptosis is a 
major process in the progression of advanced atherosclerosis and cell models show 
that prolonged ER stress is responsible for CHOP-mediated macrophage apoptosis 
through ER release of calcium and Ca2+/calmodulin-dependent protein kinases II 
(CaMKII) (Ozcan and Tabas, 2012) . Overall, chronic ER stress plays an important 
role in the development of insulin resistance and endothelial dysfunction resulting in 
increased risk of type 2 diabetes and associated CVD. 
  
The use of anti-oxidants has been trialled to prevent chronic diseases caused 
by oxidative stress (Lippman et al., 2009; Goodman et al., 2011; Rayman, 2012). 
Dietary supplements such as the trace element Se, which is required for the 
synthesis of the anti-oxidant selenoproteins (Brenneisen, Steinbrenner and Sies, 
Page 104 of 167 
 
2005; Lipinski, 2011) have been used to reduce the effects of oxidative stress in 
various disease states including cancer, neurodegenerative disorders, type 2 
diabetes and CVD (Rayman, 2012; Pillai, Uyehara-Lock and Bellinger, 2014). 
However, increasing evidence from human, animal and in vitro studies suggests that 
both low and high Se concentrations are associated with increased risk of type 2 
diabetes and CVD (Bleys, Navas-Acien and Guallar, 2007; Bleys et al., 2008; 
Labunskyy et al., 2011; Rayman et al., 2012; Rayman and Stranges, 2013; Rocourt 
and Cheng, 2013; Zhou, Huang and Lei, 2013) making inappropriately high or low 
Se intakes yet another risk factor for cardio-metabolic disorders. The aim of the 
study was therefore to investigate the effect of high Se induced ER stress in 
endothelial function.  
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4.2 Results 
 
4.2.1 ER stress response induced by high selenium impairs nitric oxide (NO) 
bioavailability in endothelial cells.  
 
NO is a biomolecule involved in the regulation of vascular tone and anti-
arteriosclerotic effects. Reduced NO bioavailability is one of the hallmarks of 
endothelial dysfunction, an independent predictor of future adverse cardiovascular 
events. Apoptotic endothelial cells are dysfunctional and exhibit reduced production 
of NO. Therefore, we decided to assess the effect of ER stress induced by high Se 
on endothelial function and apoptosis by measuring NO production using the Griess 
indirect assay.  
 
EA.hy926 endothelial cells were treated with physiological or high 
concentrations of sodium selenite in the presence or absence of chemical chaperone 
PBA for 24 hours. Then, culture medium was removed and their content in 
nitrite/nitrate that is proportional to the amounts of NO produced was determined 
using the Griess assay.  
As observed in Figure 4.1, high selenite concentrations (5 and 10 μM), but not 
the physiological concentration (0.5 μM), caused a significant decrease in NO 
production as evidenced by the reduction in nitrite levels. Importantly, the pre-
treatment of cells with the chemical chaperone PBA completely prevented the 
decrease in NO production caused by high Se, suggesting the potential involvement 
of the ER stress response in this effect. 
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Figure 4.1. High Se-induced ER stress response impairs nitric oxide (NO) 
bioavailability in endothelial cells. The bar chart shows nitrite concentration levels (μM), 
which are proportional to NO production, in EA.hy926 cells treated with various 
concentrations of sodium selenite in the presence or absence of PBA. Values are expressed 
as mean ± SEM were analyzed two-way ANOVA, followed by Bonferroni‘s multiple 
comparison test.*P<0.05, **P<0.01 and  ***P<0.001 vs control. N = 4 in each group. 
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To further assess the potential effect of high-Se-induced ER stress on endothelial 
function, we analysed by western blot the expression and phosphorylation of 
endothelial nitric oxide synthase (eNOS) at Ser 1177 which is recognised as the key 
amino acid residue in the active site of the enzyme. Also, we analysed the 
expression of phosphorylated Akt, a protein that when phosphorylated through the 
PI(3)KI/Akt pathway influences the phosphorylation of eNOS for NO production in a 
Ca2+ independent manner. Treating HUVECs with high selenite concentrations (5 
and 10 μM) non significantly decreased the phosphorylation of Akt on serine 473 
compared to untreated cells and cells treated with physiological concentration (0.5 
μM) as shown in Figures 4.2A and B; indicating that high selenite concentrations 
impairs the PI(3)KI/Akt pathway in endothelial cells. In addition, HUVECs with 5 and 
10 µM of selenite showed a non-significant reduction in phosphorylation of eNOS on 
serine 1177 (p>0.05), (Figures 4.2C and D).  However, co-treatment of HUVECs with 
PBA and selenite significantly reduced the phosphorylated Akt levels (p<0.001) as 
seen in Figure 4.2B. Interestingly, the quantitative analysis showed a non-significant 
improvement of phosphorylated eNOS levels (p>0.05) as depicted in Figure 4.2D 
compared to phosphorylated Akt in endothelial cells co-treated with PBA and high 
selenite concentrations (5 and 10 µM). The result in Figure 4.2 D suggest a possible 
involvement of the chemical chaperone PBA in ameliorating the Se-induced ER 
stress response.   
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Figure 4.2. Effect of high Se treatments on expression of Akt and eNOS 
phosphorylation. Effect of Se in the form of selenite on Akt phosphorylation (A and B) and 
eNOS phosphorylation (C and D) in HUVECs treated with varying concentrations of selenite 
in the presence or absence of PBA for 24 hours. The protein expression was corrected to 
total Akt and total eNOS respectively.β-actin was used as a loading control.  (***P<0.0001 
vs. CTL Data (B and D) are expressed as mean ±SEM (p<0.05) and were analyzed one-way 
ANOVA, followed by Dunnett‘s multiple comparison test. The blots shown are representative 
of 3 independent experiments. 
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4.2.2. High-selenium-induced ER stress response enhances oxidative stress in 
endothelial cells  
 
Se (as selenoproteins) has anti-oxidant properties; however supra-nutritional doses 
of this trace element have been reported to be associated with ROS induction (Guan 
et al., 2009; Wang et al., 2014). ROS and ER stress can co-exist in an 
interconnected relationship where one can be both a cause and a consequence of 
the other (Malhotra and Kaufman, 2007). Oxidative stress, ROS, is known to reduce 
NO bioavailability in the system and participate in the pathogenesis of endothelial 
dysfunction. ROS, particularly superoxide (O2
–) (Levick, 2003; Bashan et al., 2009). 
Therefore, we aimed to determine the effect of high concentrations of Se on ROS 
generation, specifically of superoxide (O2
–), the main ROS in the vasculature. Cells 
were treated with various amounts of selenite or positive control of H2O2 (100 μM) in 
the presence or absence of the chemical chaperone PBA. Then cells were stained 
with DHE dye before analysing the percentage of positive cells by flow cytometry (for 
experimental details, refer to chapter 2). DHE dye reacts with superoxide to form a 
DNA binding fluorescent product. The amount florescent produced is proportional to 
the amount of superoxide present in the cells (Zhao et al., 2003).  
As shown in Figure 4.3A, both high concentrations of selenite (5 and 10 μM) 
and H2O2 treatment dramatically increased the percentage of DHE-stained cells to 
60% (p<0.01) compared to the physiological concentration of selenite (0.5 μM) and 
negative control, 21% and 20% respectively, indicating selenite treatment induces 
oxidative stress. Importantly, the pre-treatment of endothelial cells with PBA 
completely prevented pro-oxidative effects of high concentrations of selenite, 
indicating that PBA may have a protective role against oxidative stress induction. 
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Figure 4.3. High Se-induced ER stress response enhances oxidative stress in 
endothelial cells. Measurement of ROS production in endothelial cells. Cells were treated 
with different concentrations of sodium selenite or the positive control, H2O2 (100 μM), in the 
presence or absence of PBA. Cells were treated with the fluorescent dye DHE (10 μM) and 
the percentage of fluorescent-positive cells was determined by flow cytometry, as shown on 
chart B. The results (A) are expressed as mean ± SEM of five independent experiments and 
were analysed using one-way ANOVA followed by Tukey multiple post-hoc test. 
Representative histograms of flow cytometry are shown below. ***P<0.0001 vs control 
(CTL). N=4 in each group.  
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4.3. Discussion. 
 
Endothelial cells line up the vasculature to allow blood flow throughout the body. Any 
changes in the function of endothelial cells leads to endothelial dysfunction and 
presiding factor to atherosclerosis, which in turn is a hallmark for increased CVDs. 
Se as an important constituent of selenoproteins involved in redox homeostasis, 
immunity, cell metabolism and thyroid function, has been implicated in the increased 
risk of CVDs (Rayman, 2012). On the other hand, high Se concentration has been 
shown to induced ER stress mediated cell death in some cancer cells (Wu et al., 
2005). Some recent studies have shown that ER stress activation in models of 
diabetes and hypertension is associated with endothelial dysfunction, the initial step 
for the development of atherosclerosis (Basha et al., 2012), therefore the aim of the 
study was to investigate the effect of high Se induced ER stress in endothelial 
function using Human Umbilical Vein cells (HUVECs) as a endothelium model.  
 
Our results show that high Se leads to the induction of ER stress markers, as 
shown in chapter 3.  Moreover, the experiments presented in this chapter indicate 
that high Se treatment in endothelial cells leads to molecular changes that are 
consistent with ER stress induction. To assess the consequences of high-Se induced 
ER stress on endothelial function, we evaluated the effects of selenite treatment on 
NO release. Firstly, our results show that endothelial cells treated with high Se 
concentrations had reduced production of nitrite levels, indicating reduced bio-
availability of NO upon high Se. Importantly, HUVECs co-treated with PBA, a 
chemical chaperone thought to act by inhibiting ER stress induction, significantly 
improved nitrite production by the endothelial cells. Nitrite measurement is used to 
indicate NO bioavailability because the half-life of NO in biological samples is less 
than one second, as it is rapidly converted to nitrite and nitrate in the presence of 
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oxygen and oxyheamoglobin (Privat et al., 1997).  Nitrite and nitrate are therefore 
metabolites of NO produced by the endothelium and either are frequently used to 
measure the amount of NO produced by the endothelial cells as a marker of 
endothelial function (Privat et al., 1997). The nitrite levels produced are directly 
proportional to the amount of NO produced (Privat et al., 1997).   
 
Reduced NO production is an important component of hypertension 
(Hermann, Flammer and Lscher, 2006), and therefore plays a role in endothelial 
dysfunction (Schulz, Gori and Münzel, 2011).  Several studies have demonstrated 
that high Se intake is inversely associated with CVDs and cardio-metabolic state 
(Bleys, Navas-Acien and Guallar, 2008; S. Stranges et al., 2010). Furthermore, 
several studies have shown contradicting relationship between high Se intake or Se 
supplementation and  increased blood plasma lipids such as triglycerides and high 
density lipoproteins (Laclaustra et al., 2010; Rayman et al., 2011), hence more  
interventional clinical trial must be done to clarify the relationship between high Se 
intake and endothelial dysfunction and CVDs and establish the molecular 
mechanism involved. Thus, our results in cultured cells showed that high Se 
concentrations leads to endothelial dysfunction genuinely and therefore might lead to 
increased CVDs risks. Additionally, owing to the fact that the use of a chemical 
chaperone, PBA, increased levels of NO, the results suggest that ER stress is a 
mechanism involved in high Se-induced endothelial dysfunction. Interestingly, ER 
stress activation in response to high Se treatment in endothelial cells reduced the 
phosphorylation of both AKT on serine 473 and eNOS on serine 1177. Our results 
indicate the mechanism of action in ER stress-induced endothelial dysfunction in 
high Se intake is through impaired phosphorylation of AKT at serine 473. It is 
imperative to mention that there are no comparative studies that measured NO or 
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NO metabolites to assess the effect of high Se on cardiovascular risks or endothelial 
dysfunction.  
 
It has been long established that low Se deficiency leads to a cardiomyopathy 
known as Keshan disease which can be reversed trough Se supplementation (Chen 
et al., 1980). Although several observational studies have shown that there is an 
inverse association between high Se intake/levels and risk of CVD especially in 
selenium sufficient population (Bleys, Navas-Acien and Guallar, 2007; Bleys et al., 
2008; S Stranges et al., 2010), some of the clinical trials done across the world show 
inconsistent conclusion between the high Se intake and high risk of CVD. Post hoc 
analysis of randomised trial particularly the Nutritional Prevention of Cancer trial 
done in Eastern United States of America showed that there is high risk of type 2 
diabetes among participants with high baseline plasma Se supplemented with high 
dose of Se (200 g/ day) compared to placebo (Stranges et al., 2007). As type 2 
diabetes is intimately associated with cardiovascular risks the results brought 
concerns on high Se and cardiovascular risks, however a review on Se and CVDs 
indicated that results from randomised controlled trials on the role of Se on CVDs are 
inconclusive (Rees et al., 2013).  
 
In addition, there is little to no evidence for a potential effect of high Se on 
endothelial cells. However, studies in diabetic animal models indicate that high Se 
impairs insulin signalling through the depletion of hydrogen peroxide needed to keep 
phosphatase and tensin homolog (PTEN) protein inactive. Physiological amount of 
H2O2 is needed in muscles to keep PTEN enzyme inactive to allow thee 
translocation of Glucose transporter type 4 (GLUT4) to the cell surface during insulin 
signalling However, studies have shown that overexpression of selenoproteins, such 
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as SelP and GPx4, quench H2O2, activating PTEN which then leads to impaired 
signalling of the PI(3)KI and impaired insulin signalling thereby leading to insulin 
resistance and insulin resistance associated-endothelial dysfunction (Steinbrenner, 
2013). 
 
ER stress is reportedly associated with oxidative stress, both as a cause and 
a consequence (Malhotra and Kaufman, 2007). Oxidative stress may thus in turn 
further reduce NO bioavailability in the system and participate in the pathogenesis of 
endothelial dysfunction. Indeed, reactive oxygen species (ROS), particularly 
superoxide (O2
–) can react very quickly with NO to produce peroxynitrite, another 
potent free radical, thus reducing the amounts of available NO. Se is known for its 
anti-oxidant activity but this is when present as selenoproteins; supra-nutritional 
doses of Se, as selenite, were reported to increase the production of ROS. Wang 
and others (Wang et al., 2014)  observed that high Se intake (selenite) in rats lead to 
a dramatic increase in ROS production in the liver thus impairing insulin signalling 
and causing hepatic insulin resistance.  Consistent with these observations, we 
found that the treatment of endothelial cells with supra-nutritional concentrations of 
selenite (5-20 μM) increased ROS production and that this accumulation of ROS was 
prevented by the chemical chaperone PBA. 
  
Moreover, our results in endothelial cells shows the increase in the expression 
of ER stress markers such as CHOP mRNA has been observed as early as 8 hours 
post selenite treatment while the increase in ROS production was observed later on 
at 24 hours. This suggests that ER stress is likely to be a mechanism involved 
preceding oxidative stress in endothelial cells but more detailed and conclusive time 
points are need to confirm. Oxidative stress may affect endothelial function in various 
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ways including the reduction of NO bioavailability. However, the accumulation of 
ROS can also inactivate the phosphorylation of the insulin receptor on tyrosine 
residues leading to endothelial insulin resistance which is also known to participate 
in the onset of endothelial dysfunction (Bashan et al., 2009). There is evidence to 
suggest that disrupted endothelial insulin signalling may disturb endothelial function. 
Insulin stimulates endothelial cell production of nitric oxide (NO), and, therefore, local 
insulin resistance at the level of the endothelium is expected to be associated with 
reduced insulin-stimulated NO (Rains and Jain, 2011; Tiganis, 2011). One 
recommendation from the study is to investigate the effects of high Se-induced ER 
stress and oxidative stress on the insulin signalling pathway in endothelial cells.  
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Chapter 5 Results 
High Selenium Induced ER stress leads to 
impaired angiogenic capacity and 
apoptosis 
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5.1. Introduction 
 
Oxidative stress and insulin resistance have been associated with impaired 
angiogenesis, a dominant marker of endothelial dysfunction and a cause of 
blindness in diabetic patients (Cheng and Ma, 2015). Angiogenesis is an important 
feature in normal physiology and several pathological processes that promotes and 
enhances the formation of new blood vessels from pre-existing vessels (Carmeliet, 
2005). Angiogenesis involves endothelial cell migration, proliferation and 
differentiation to promote tissue survival after ischemic events and aid in tissue 
repair after an injury hence it is considered essential in wound repairing and 
therefore often studied as a mechanism of wound healing (Strømblad and Cheresh, 
1996; Carmeliet, 2005; Kolluru et al., 2012; Johnson and Wilgus, 2014). Few adults‘ 
tissues that require ongoing angiogenesis include female reproductive organs, 
injured tissue such as in heart attack and myocardial infarction and also organs 
undergoing physiological growth (Ferrara, 1999; Levick, 2003).  
  
Angiogenesis is controlled through the production of a precise balanced 
growth and inhibitory factors in healthy tissues and it is tightly regulated (Adams and 
Alitalo, 2007; Shibuya, 2011). Angiogenesis is tightly regulated by the pro-angiogenic 
and anti-angiogenic factors that act on endothelial cells to induce or inhibit 
endothelial growth and migration in order to initiate angiogenesis (Adams and Alitalo, 
2007). Vascular endothelial growth factor (VEGF-A), platelet activating factor (PAF) 
and fibroblast growth factors are important pro-angiogenic activators needed for 
stimulating endothelial cell growth and migration in order to initiate angiogenesis . 
VEGF-A is the most important molecule that control the morphogenesis of the blood 
vessels and is abundant in tissues consistently forming new vessels such as 
tumours, diabetic retina and myocardium and endothelium (Adams and Alitalo, 2007; 
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Johnson and Wilgus, 2014). In tumour angiogenesis, commonly called angiogenic 
switch, the blood vessels fail to become quiescent enabling constant new growth of 
blood vessels compared to physiological angiogenesis in which the regulation is 
tightly controlled (Adams and Alitalo, 2007). 
  
During angiogenic switch, physiological stimuli such as hypoxia, oncogenic 
stimuli or tumour suppression mutation and anti-cancer agent tip the balance  in 
favour of pro-angiogenesis (Adams and Alitalo, 2007; Johnson and Wilgus, 2014) 
increasing expression of angiogenic activators especially VEGF-A and activation of 
angiogenic genes in endothelial cells. High levels of VEGF-A allows initiation of 
angiogenesis in quiescent endothelial cells while inhibition of VEGF-A stimulates 
apoptosis of endothelial cells (Johnson and Wilgus, 2014). Wang and colleagues 
showed that high glucose induced apoptosis in endothelial cells through down 
regulation of VEGF mRNA expression. The study showed that pre-treating cells with 
endogenous VEGFA prevented high glucose mediated apoptosis (Yang et al., 2008). 
Moreover, some studies have shown that VEGF resistance leads to impaired 
angiogenesis in type 2 diabetes resulting in development of various vascular 
complications associated with type 2 diabetes (Shibuya, 2011) however the 
molecular mechanism is not fully understood.  
 
The role of angiogenesis in health has been mainly studied in diabetic animals 
because impaired angiogenesis is a marker of vascular complications in type 2 
diabetes (Kolluru et al., 2012; Cheng and Ma, 2015). Vascular complications 
associated with type 2 diabetes are grouped as microvascular and macrovascular. 
Microvascular complications include retinopathy, diabetic nephropathy and 
neuropathy which all are resultant of impaired angiogenesis (Levick, 2003); 
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macrovascular complications include CVD and ischemic heart failure. Both the 
diabetic micro- and macrovascular disease are marked by endothelial dysfunction, a 
hallmark of atherosclerosis (Levick, 2003). A form of CVD known as Keshan disease 
is a cardiomyopathy known to be caused by low Se deficiency, but is prevented by 
Se supplementation (Chen et al., 1980; Thomson, 2004). Several meta-analysis and 
cross-sectional studies have outlined a ―U‖ shaped relationship between Se levels 
and CVD, i.e. low Se intake (<90 µg/day) leads to cardiomyopathy and, on the other 
hand, high Se intake (>190 µg/day) also increases the risk of CVD (Bleys et al., 
2009; Laclaustra et al., 2010; Rayman, 2012; Rayman and Stranges, 2013). The 
molecular mechanism causing this increased risk of CVDs as a result of high Se 
intake is yet to be identified. However, oxidative stress has been linked as a 
mechanism behind low and high Se induced cardiovascular events (Rees et al., 
2013). The role of Se, as an anti-oxidant agent, in endothelial function and CVDs has 
been well investigated (Chen et al., 1980; Burk, 2002; Rees et al., 2013; Pillai, 
Uyehara-Lock and Bellinger, 2014) and several studies have shown the implication 
of Se in angiogenesis (Jiang et al. 2000; Shi et al. 2013; Ishikura et al. 2014).  
 
Methylselenol (CH3SeH), a metabolite of selenate and selenite, was shown to 
have inhibitory effects on the expression of key molecules involved in angiogenesis 
(Jiang, Ganther and Lu, 2000; Shi et al., 2013). Selenoprotein P (SeP) SeP has 
been found to be elevated in serum of patients with impaired glucose tolerance; SeP 
is found to impair insulin signalling resulting in insulin resistance; (Yang et al., 2000) 
thus leading to the interest in the role of Se in angiogenesis . Recently, it has been 
shown that liver derived SeP impairs the VEGF-induced angiogenesis in HUVECs 
(Ishikura et al., 2014). In the absences of SeP, VEGF did not interfere with HUVECs 
migration and formation of tube like structures in in vitro angiogenesis assay unlike in 
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cells co-treated with SeP and VEGF. The results further showed delayed wound 
healing in skins crafts of mice with wild type Sepp1 but mice with Sepp1-/- mice 
showed improved wound healing (Ishikura et al., 2014) validating that Se therefore 
impairs angiogenesis. The propose that, increased SeP act as anti-oxidant and 
depletes the physiological amount of ROS present in cells necessary to activates the 
phosphorylation of VEGF receptor thereby impairing angiogenesis (Ishikura et al., 
2014).  Se is a cofactor for thioredoxin (TrxR) reductase which has pro-angiogenic 
potential (Streicher et al., 2004; Dunn et al., 2010). The investigation on the changes 
of the Se-dependent enzyme, TrxR in controlling angiogenesis revealed that 
inhibited levels of TrxR increased VEGF expression leading to quicker angiogenic 
response in bovine mammary endothelial cells (Streicher et al., 2004). The studies 
shows that low Se status increases angiogenesis while high Se levels impaired 
angiogenesis. 
  
Animal model studies have associated low Se status to increased 
angiogenesis in rat mammary carcinomas perhaps due to reduced inhibitory effect of 
Se as an anti-oxidant on physiological ROS needed for activation of VEGF receptor 
to promote angiogenesis (Jiang et al., 1999) . However, the mechanism behind 
increased angiogenesis due to low Se levels is not fully established. In cultured cells, 
one paper investigated the role of TrxR in endothelial derived VEGF production and 
angiogenic development from Se deficient and Se supplemented bovine mammary 
endothelial cells (BMECs). The study found that chemical inhibition of selenoproteins 
TrxR stimulated cell proliferation, migration and angiogenesis in cells deficient with 
Se compared to Se supplemented BMECs (Streicher et al., 2004). BMECs with 
inhibited TrxR and Se supplementation had reduced cell proliferation, VEGF 
production and impaired angiogenesis compared to cells with Se deficiency and 
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normal TrxR activity (Streicher et al., 2004). The authors concluded that inhibited 
selenoproteins TrxR are more essential than Se status for VEGF production, cell 
proliferation and angiogenesis (Streicher et al., 2004) showing the essential role of 
selenoproteins in angiogenesis. In addition the studies suggest that high Se status or 
high selenoprotein activity impairs angiogenesis. 
  
Biological mechanisms behind Se-induced endothelial dysfunction or 
angiogenesis are complicated and maybe linked to the dual role of Se as a toxic 
agent at high doses or concentrations or as an essential element important in 
formation of antioxidant selenoproteins. Increasing the doses or the intake of Se 
increases the formation of selenoproteins particularly glutathione peroxidase, but the 
dose-response reaches a plateau between 70-90 ng/mL (~1.5 µM) (Thomson, 2004).  
Thus, high Se doses or concentrations could potentially increase cardiovascular 
events in population with optimal Se levels. Excessive Se has been shown to impair 
micro vessel formation and promote apoptosis in endothelial cells, however Se 
deficiency has opposing effects of promoting micro vessel formation and impairing 
apoptosis  (Dunn et al., 2010).  
 
The contradictory effects of Se levels on health and diseases are yet to be 
understood although it is thought that there are some unidentified compensatory 
redox mechanisms that are induced by excessive or depleted Se levels. A number of 
studies have proposed that Se supplementation in Se deficient or Se naïve patients 
prevent atherosclerotic diseases due to its involvement in the formation of anti-
oxidant proteins known as selenoproteins (Flores-Mateo et al., 2006; Bleys et al., 
2008; Rees et al., 2013), however, few meta-analysis studies have shown that there 
is a statistically significant inverse association between high Se intake and CVD 
Page 122 of 167 
 
(Jossa et al., 1991; Flores-Mateo et al., 2006; Bleys et al., 2009; S Stranges et al., 
2010).  
 
Se is actively promoted across the world as an antioxidant nutrient and 
therefore there is a need to understand the efficacy, mechanism of action and effect 
on health and diseases. One potential mechanism underlying Se‘s role in 
pathophysiology is its potential to stimulate ER stress induction. Several studies 
have linked ER stress to insulin resistance and type 2 diabetes (Araki, Oyadomari 
and Mori, 2003; Ozcan et al., 2004, 2006; Hummasti and Hotamisligil, 2010). At the 
same time Se has been associated with type 2 diabetes and CVDs ( Stranges et al. 
2010; Stranges et al. 2007; Steinbrenner et al. 2011; Laclaustra et al. 2010; Rayman 
& Stranges 2013; Rayman 2012; Bleys, Navas-Acien & Guallar 2008).  However, 
few studies have linked the role of Se induced ER stress to the aetiology or 
progression of type 2 diabetes and other human diseases (Wu et al., 2005; Zu et al., 
2006; Hwang et al., 2007; Wallenberg et al., 2014). Moreover, the role of Se-induced 
ER stress on endothelial dysfunction or diabetes-complication vascular disease 
complicated is not known. Since endothelial dysfunction in diabetes happens through 
impaired angiogenic capacity, we therefore investigated the activation of ER stress in 
Se-induced endothelial dysfunction measuring angiogenic capacity as a marker of 
endothelial dysfunction.  
 
A number of studies on cultured endothelial cells, animal models and humans 
have linked ER stress to endothelial dysfunction (Sheikh-Ali et al., 2010; Basha et 
al., 2012; Kassan et al., 2012; Ozcan and Tabas, 2012; Galán et al., 2014). 
Homocysteine has been found to be a risk factor in CVD and in cultured endothelial 
cells; it has been established that homocysteine induces the IRE1 pathway and 
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subsequently activates CHOP resulting in ER stress mediated-endothelial cell death 
(Zhang et al., 2001). Davies and co-workers (2013) demonstrated the relationship 
between disturbed blood flow and ER stress activation and found elevated mRNA 
expression of ER stress markers at anatomical sites where there is disturbed blood 
flow, here termed as atherosclerosis, from pig‘s aortic arches (Davies et al., 2013). 
Protein analysis showed that in sites with disturbed blood flow there is activation of 
IRE1a and ATF6 pathways showing that ER stress is associated with shear stress. 
Shear stress is ―a biomechanical force determined by blood flow‖ (Cunningham and 
Gotlieb, 2005). Disturbed shear stress triggers endothelial dysfunction by decreasing 
vascular wall function due to low endothelial nitric oxide synthase (eNOS) 
production, low vasodilation and low endothelial repair coupled with increased ROS 
and apoptosis eventually leading to atherosclerosis followed by ischemic injury and 
CVD (Cunningham and Gotlieb, 2005).   Angiogenesis can therefore be considered a 
marker of endothelial dysfunction and an indicator of atherosclerosis. As it has been 
outlined that ER stress is linked to atherosclerosis, our aim was to investigate the 
role of Se-induced ER stress in angiogenesis in normal human endothelial cells. 
   
Current studies have exposed a link between ER stress markers and the 
angiogenesis process (Dong et al., 2011; Lenna, Han and Trojanowska, 2014; Urra 
and Hetz, 2014; Binet and Sapieha, 2015). GRP78/BiP overexpression has been 
reported in synovium of rheumatoid arthritis patients, in contrast to mice models in 
which GRP78/BiP activation was linked to VEGF-induced angiogenesis (Lenna, Han 
and Trojanowska, 2014). One study was investigating the role of GRP78 in tumour 
growth by looking at the early phase of tumour growth called neovascularization also 
known as tumour angiogenesis; the study found that in heterozygote GRP78+/- mice 
implanted with E0771 breast cancer cells, there was a 70% reduction in  tumour 
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angiogenesis compared to GRP78 +/+ mice (Dong et al., 2011). The results showed 
that not only ER stress in involved in tumour angiogenesis but overexpression of ER 
stress markers inhibits angiogenesis in the early phases of cancer compared to the 
late phase of tumour implantation (Dong et al., 2011).   
 
The use of chemical chaperones to alleviate ER stress as a treatment of 
action for various disorders such as in insulin resistance has proven to be beneficial 
although the molecular mechanism is not known. PBA and TUDCA have been 
shown to be potential therapeutic agents in the treatment of ER stress related 
diseases like rheumatoid arthritis, neurodegenerative diseases, Alzheimer‘s, TCA 
cycle disorders and insulin resistance (Ozcan et al., 2006; Engin and Hotamisligil, 
2010; Kuang et al., 2010; Galán et al., 2014; Humeres et al., 2014; Liu et al., 2016). 
Although literature review so far shows an association between Se and angiogenesis 
as well as ER stress as a mechanism involved in impaired angiogenesis, there is no 
information on the role of ER stress induction on impaired angiogenesis due to high 
Se intake or concentrations.  
 
Several studies have shown that upon unresolved ER stress, an apoptotic 
cascade is activated through the induction of CHOP (Hetz, 2012). It has been well 
established that during ER stress, the PERK-eIF2α-ATF4 axis is stimulates CHOP 
induction (Szegezdi et al., 2006; Hetz, 2012) . CHOP works as a transcriptional 
factor that regulates signalling proteins working in the apoptotic pathway; 
researchers have established that Chop-/- mice and cells (mouse pancreatic beta 
cells and mouse embryonic fibroblasts) are resistant to ER stress-induced apoptosis 
thereby proposing the role of CHOP in ER stress-induced cell death (Oyadomari et 
al., 2001; Szegezdi et al., 2006). CHOP has been found to regulate pro-survival and 
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anti-survival proteins involved in apoptosis such as B-cell lymphoma-2 (Bcl-2) and 
BAX, respectively (Szegezdi et al., 2006).  A study found that cells which 
constitutively overexpress CHOP genes had reduced cell survival and increased 
apoptosis once treated with ER stress inducers thapsigargin and tunicamycin 
(McCullough et al., 2001).  The study further elaborated that overexpression of 
chop/gadd153 genes down-regulated the expression of bcl2 genes and reduced 
levels of Bcl-2 proteins (McCullough et al., 2001). Bcl-2 protein is an anti-apoptotic 
marker therefore overexpression of chop/gadd153 gene led to increased production 
of CHOP protein. The results suggest that ER stress-mediated apoptosis is 
regulated by BCL2 family of proteins which includes the anti-apoptotic Bcl-2 and the 
pro-apoptotic BAX/BAK protein.  Furthermore, induction of CHOP leads to 
translocation of the BAX/BAK, a pro-apoptotic protein, from cytosol to the 
mitochondria to activate caspases-3 mediated apoptosis also known as 
mitochondria-mediated apoptosis during chronic ER stress (Schröder, 2008; Sano 
and Reed, 2013).  
 
Although the regulation of BAX/BAK and Bcl-2 proteins by ER stress in no 
well understood, it is postulated that c-Jun kinase (JNK) is activated during activation 
ER stress (activation of the IRE1α) and JNK phosphorylates the Bcl-2 localised in 
the ER and BIM, the pro-apoptotic protein, leading to the activation of the caspase 
activation (Szegezdi et al., 2006; Sano and Reed, 2013) via the mitochondrial 
induced apoptosis. It is worth mentioning that cytochrome c is not essential for ER 
stress–induced apoptosis through caspases activation because, murine cells 
(C2C12 cells) have been shown to go through ER stress induced apoptosis without 
the release of cytochrome c from the mitochondria. The study showed that 
thapsigargin or tunicamycin treated C2C12 cells have the same amount of 
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cytochrome c release as the untreated but there was direct activation of caspases 9 
by caspase 12 (Morishima et al., 2002).  
Cysteine-dependent aspartate-directed proteases (Caspases) are central 
regulators of apoptosis; initiator caspases (Caspases-2, -8, -9, -10, -11 and -12) 
intimately coupled with effector caspases (Caspases-3, -6 and -7) to execute the 
apoptosis pathway (Elmore, 2007; Fuchs and Steller, 2011). The initiator caspase 
once cleaved, is active and will, in turn activate the effector caspases to promote 
apoptosis. Although mitochondria-mediated apoptosis and the role of caspases in 
apoptosis pathway is well documented (Elmore, 2007), the role of caspases on ER 
stress-induced apoptosis is not conclusively ascertained. Even though it has been 
shown that some caspases are participating in ER stress induced apoptosis, the 
identity of specific caspases involved in ER stress-induced apoptosis are yet to be 
fully identified. Nonetheless, caspase 12 has been implicated as an essential 
mediator in ER stress-induced apoptosis in rodents.  
 
Caspase 12 is only expressed in rodents, but silent in humans. Therefore, 
caspase 12 does not play a role in ER stress-induced apoptosis in human cell lines 
and primary cells; instead it has been shown been that caspase 4 has a similar role 
in human cell studies (Morishima et al., 2002; Hitomi et al., 2004; Szegezdi et al., 
2006). Nevertheless, murine cells treated with either tunicamycin or thapsigargin 
triggered activation of caspase 12, 9 and 3 independent of cytochrome c release 
(Morishima et al., 2002). ER stress inducers activates caspase 12 which cleaves and 
activates caspase 9 to initiate ER stress mediated apoptosis (Morishima et al., 
2002). Other caspases that are cytochrome c release dependent have been 
researched; the involvement of caspase 2, -3 and 7 have been linked to ER stress 
induced apoptosis (Morishima et al., 2002; Cheung et al., 2006; Tabas and Ron, 
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2011). For example one study showed that treatment of glomerular mesangial cells 
with advanced glycation end-products (AGEs) induced caspase 3 mediated-
apoptosis in a dose dependent manner via ER stress induction (Chiang, et al., 
2016).  
 
It has been shown that Se activates CHOP expression in leukemic cells 
thereby leading to apoptosis termed as ER stress mediated apoptosis (Wu et al., 
2005). Methylseleninic acid (MSA) induces ER stress in the human prostate cancer 
cell lines (PC-3 cells) and furthermore induced ER stress mediated apoptosis in a 
dose dependent manner (Wu et al., 2005). The results of this former study indicated 
that 10 µM of MSA induced ER stress markers phospho-PERK, GRP78/BiP and 
phospho-eIF2 from 6 hours to 15 hours. Furthermore, as the ER stress associated-
apoptotic markers (cleaved caspase 12, PARP and CHOP) increased proportionally 
with the dose of MSA the markers of ER stress decreased while overexpression of 
GRP78/BiP alleviates MSA-induced ER stress (Wu et al., 2005). 
  
Recently, a study to investigate the ability of MSA and selenite to kill primary 
effusion lymphoma cell lines and the mechanisms involved in the cell death 
associated to the mentioned Se compounds was reported. The study concluded that 
MSA and selenite induce apoptosis through the activation of caspase 3, caspase 7 
and caspase 9 with the activation of caspase 9 prominent in MSA induced apoptosis 
(Szegezdi et al., 2006; Xiang, Zhao and Zhong, 2009; Uguz and Naziroglu, 2012) 
(Shigemi, et al., 2017). Furthermore, MSA and selenite induced apoptosis activated 
via the ER stress pathway though CHOP expression (Shigemi, et al., 2017). Our 
previously described results suggest that Se (selenite) induces ER stress in 
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endothelial cells however we wanted to further mechanistically investigate the impact 
of Se induced ER stress in angiogenic capacity.  
 
5.2 Results 
5.2.1. High selenium impairs angiogenesis mediated by ER stress in 
endothelial cells 
 
We investigated the effect of Se on the process of angiogenesis, a marker of 
endothelial function. We firstly compared our control growth conditions with a 
positive inducer of angiogenesis, namely VEGF-A. We found that endothelial cells 
incubated with pure growth media, supplemented with low growth cell supplements 
containing growth factors for human endothelial cells, formed a number of tube like 
structures on Matrigel® that was no different from cells treated with 50 ng/mL of 
VEGF-A (as shown in Figure 5.1). Figure 5.1B shows the quantification of these 
results, confirming that there was no significant difference between cells grown 
under our control conditions or treated with the positive angiogenesis inducer VEGF-
A. Therefore, our control conditions were adequate to promote tube-like structure 
formation in our assay, and any potential changes that occurred in cells due to the 
treatment with selenite could be assessed.  
 
Figure 5.1A shows that there is a dramatic reduction in number of tube like 
structures formed in endothelial cells treated with selenite compared to control, at 
doses of 5 µM  (19 tubes, p<0.001) and 10 µM (1 tube, p<0.0001).  Treatment with 
physiological concentrations of selenite (0.5 µM) led to a small reduction in tube-like 
structure formation, and the reduction was not statistically significant (31.8 meshes, 
p=0.1926). Interestingly, the use of chemical chaperone PBA improved angiogenesis 
in high selenite treated cells. 
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Figure 5.1. High Se impairs angiogenic capacity of endothelial cells. High selenite (5 
μM, P=0.0030 and 10 μM, P<0.0001) concentrations induced endothelial dysfunction by 
impairing process of angiogenesis through the activation of ER stress. Representative 
picture of tube-like formation on Matrigel® are shown for cells treated with various 
concentrations of selenite (A). Values represent the average number of tube like structures 
formed (B) expressed as mean ± SEM and were statistically-treated using one-way ANOVA 
followed by Tukey multiple post-hoc test. ** p<0.001, *** p<0.0001, vs CTL. N = 4 in each 
group.  
 
High selenite concentrations dramatically inhibited formation of tube like 
structures formed on the Matrigel® compared to the control. As depicted in Figure 
5.1 A, there is a distorted formation of tube like structures on endothelial cells treated 
with 5 µM of selenite. The tubes were counted with Image J Software (Angiogenesis 
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assay) to give out the number of tubes formed per well and statistical analysis was 
performed on Graph Pad Prism. Treating HUVECs with 5 M of selenite inhibited 
tube-like structure formation with 19 meshes (tube like structures) compared to the 
untreated samples with 34 meshes formed (p<0.05). Figure 5.1B shows furthermore 
highlight that there is a significant difference of the meshes formed between the 5 
µM selenite treated cells and the untreated cell with a p value of less than 0.0001 
(p<0.05). Interestingly, PBA prevented impaired angiogenic in endothelial cells 
treated with 5 µM of selenite, and the quantification represented in Figure 5.1B 
clearly depicts that there is significant difference in the number of tubes formed in 
cells treated with 5 µM of selenite only and if compared to that of cells pre-treated 
with PBA prior to selenite treatment. Furthermore, we observed the same in 
endothelial cells treated with a higher selenite concentration (10 µM).  
There was complete impairment in the formation of tube like structures in 
endothelial cells treated with 10 µM selenite, and PBA pre-treatment completely 
prevented this impairment, hence prevented impaired angiogenesis. In vitro 
angiogenesis assay shows that at 10 µM of selenite treatment the cells clumped and 
did not form tube like structures; quantitative analysis of the data shows that 1 tube 
was formed (Figure 5.1B). PBA significantly prevented or reduced this impaired 
formation of tube like structures, as an average of 26 meshes were analysed 
(p<0.0001).  Our results show that the chemical chaperone PBA prevented Se 
induced impaired angiogenesis at both 5 µM and 10 µM selenite concentrations and 
further support our conclusion that ER stress in involved in Se induced endothelial 
dysfunction.  
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5.2.2. High selenium stimulates VEGF-A expression in endothelial cells is 
mediated by ER stress and time dependent 
 
We investigated the effect of Se on mRNA expression of VEGF-A, an important 
angiogenesis activator. We compared the gene expression of VEGF-A in a time 
depended manner upon treating cells with selenite for 8 and 24 hours with varying 
concentrations of selenite in the absences or presence of PBA. The results in Figure 
5.2 show that high selenite (5 µM and 10 µM) stimulated VEGF-A gene expression in 
a dose dependent manner (5 µM; 6.3-fold, p<0.05 and 10 µM; 17.1-fold p<0.001 vs 
CTL), 8 hours‘ post-selenite treatment. However, 24 hours‘ post-selenite treatment, 
VEGF-A expression reduced to basal levels (5 µM; 0.9-fold, p=0.99 and 10 µM; 1.3-
fold, p=0.99 vs CTL). Cells co-treated with PBA and high selenite, 5 µM and 10 µM, 
showed an increase of VEGF-A expression, 5.7-fold and 5.9-fold, respectively, if 
compared to the control levels, but this increase was not statistically significant.  
At 24 hours, there was no significant effect of selenite on the expression of VEGF-A 
mRNA in endothelial cells treated with high selenite concentrations, 5 µM and 10 µM 
(1-1.3-fold, p=0.99 vs CTL) compared to the untreated and the 0.5 µM of selenite 
treated cells. In Figure 5.2B, we show that PBA moderately increased VEGF-A 
mRNA expression by approximately 2-fold in cells treated with 5 and 10 µM of 
selenite. 
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Figure 5.2. High Se increased VEGF-A mRNA expression in a time dependent manner 
in endothelial cells. HUVECs treated with only selenite for 8 hours increased VEGF-A 
mRNA expression (Figure 5.2A) in a dose dependent manner. High selenite concentrations, 
10 µM, led to a significant increase of VEGF-A mRNA expression by 15 fold, p<0.0001, post 
8 hour incubation of cells with selenite in the absence of PBA.  (Figure 5.2A). There was no 
significant change in the VEGF-A mRNA expression across selenite concentrations at 24 
hours of treatment (Figure 5.2C). Figure 5.2C shows a significant decrease of VEGF-A 
mRNA expression at high selenite from 8 hours to 24 hours. (Figure 5.2C). PBA reduced 
VEGF-A mRNA expression to basal levels like CTL. Data is expressed as mean ±SEM and 
were analysed using one-way ANOVA followed by Tukey multiple post-hoc test. *** P<0.001 
vs CTL. N = 3 in each group. Figure 5.2C Data is expressed as mean ± SEM, *p<0.05, 
****p<0.001 (two-way ANOVA followed by Bonferroni multiple post hoc test.)  
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5.2.3 High selenium induces apoptosis in endothelial cells through ER stress 
activation. 
 
To further confirm that cell death caused by high Se involves an apoptotic 
mechanism and to understand the role played by ER stress response in this effect, 
we stained endothelial cells treated or not with Se in the presence or absence of a 
chemical chaperone (PBA) with 7-ADD and Annexing V dye and then analysed by 
flow cytometry. As shown in Figure 5.3, the treatment of cells with high doses of 
selenite (5-20 µM) caused an increase in the percentage of apoptotic cells while cells 
pre-treated with the chemical chaperone PBA were protected (Figure 5.3A and 
5.3C). Furthermore, a high dose of selenite (1000 µM) also caused a significant 
increase in the percentage of apoptotic cells though cells pre-treated with the 
chemical chaperone PBA were protected (Figure 5.3B and 5.3 D).  
Altogether, apoptosis quantification by flow cytometry analysis of cells treated 
with and without PBA strongly indicates that high Se elicited apoptosis in endothelial 
cells. The protection afforded by the chemical chaperone PBA indicates apoptosis is 
induced via a mechanism potentially involving the ER stress response. 
  
Page 134 of 167 
 
 
Figure 5.3. High concentrations of Se induce apoptosis through the activation of ER 
stress. Quantification of apoptotic EA.hy926 endothelial cells treated with different doses of 
selenite in the presence or absence of PBA (A) or treated with various concentrations of 
selenate in the presence or absence of PBA (B). Representative histograms of flow 
cytometry are shown for cells treated with selenite (C) and for those treated with selenate 
(D). Values represent the percentage of apoptotic cells for each treatment and are 
expressed as mean ± SEM and were analysed using one-way ANOVA followed by Tukey 
multiple post-hoc test. *** P<0.001 vs CTL. N = 4 in each group. 
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5.2.4. High selenium causes ER stress-mediated apoptosis through the 
activation of caspases 3/7 in endothelial cells.  
 
We further investigated the apoptotic pathway involved the ER stress-mediated 
apoptosis caused by high Se intake. Compared to the untreated (CTL) cells, 5 µM of 
selenite at 8 and 24 hours significantly increased the activity of caspases 3 and 7 by 
1.5-fold (p<0.001) and 2-fold (p<0.001), respectively. Interestingly, PBA pre-
treatment completely prevented the activation of caspases 3/7 strongly indicating 
that selenite-induced ER stress can activate the executioner caspases 3/7. 
Surprisingly, higher doses of selenite (10 and 20 μM) did not affect caspase 3/7 
activity (Figure 5.4). All the experiments were corrected to the number of viable cells 
and compared to the untreated (CTL) experiment.  1 µM of staurosporine was used 
as a positive apoptosis inducer.  
 
Figure 5.4. High Se causes ER stress-mediated apoptosis through the activation of 
caspases 3/7 in endothelial cells. Caspases 3/7 activity in EA.hy926 endothelial cells 
treated with various doses of selenite or staurosporine (positive control or PC) in the 
presence or absence of PBA for 8 hours (A) or 24 hours (B). High selenite concentrations (5 
µM) showed high activation of caspases 3/7 at both 8 and 24 hours. PBA reduced the 
activation of caspases 3/7. Values represent the percentage of caspases 3/7 activity as % of 
control (CTL) and are expressed as mean ± SEM and were analysed using one-way ANOVA 
followed by Tukey multiple post-hoc test. *** P<0.001 vs indicated groups. N = 3 in each 
group. 
 
  
Page 136 of 167 
 
5.3 Discussion 
 
The aim of this study was to investigate the impact of Se induced ER stress in 
angiogenic capacity of endothelial cells and mechanism involved. This is the first 
study to investigate the effect of Se-induced ER stress in angiogenesis and to 
demonstrate that Se in the form of selenite impairs angiogenic capacity in human 
primary cells. The present data showed that high Se intake prevented formation of 
tube like structures in the Matrigel® showing that high Se concentration impairs 
angiogenesis, highlighting the fact that high Se intake result in endothelial 
dysfunction. Interestingly the use of the chemical chaperone PBA, prevented 
impaired angiogenesis in cells treated with high Se concentrations (5 µM and 10 µM) 
of Se sources. This strongly suggests that ER stress mechanism are involved in 
impaired angiogenesis due to high Se intake.  
 
 The growth of new blood vessels by angiogenesis is essential for wound and 
tissue repairing and in cancer physiology in tumour progression (Carmeliet, 2005). 
Blood vessels growth is significantly affected by the VEGF-A that is secreted by 
macrophages, cancer cells during hypoxia and endothelial cells (Folkman and Shing, 
1992). Few studies have found that low Se status increased production of VEGF-A 
post angiogenic development (Jiang et al., 1999; Jiang, Ganther and Lu, 2000; 
Streicher et al., 2004). Additionally, TrxR inhibited bovine mammalian endothelial 
cells (BMECs) supplemented with 20 ng/mL of selenite showed increased protein 
expression of VEGF-A but had less tube formation compared to Se deficient BMECs 
in an in vitro angiogenesis assay (Streicher et al., 2004).  
 
Our results as shown in Figure 5.1 agree with Streicher results showing that 
high Se supplementation prevents tube formation. However, the Streicher study 
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used lower selenite concentration of 20 ng/mL (0.12 µM) in bovine mammary cells 
compared to our study in which we used endothelial cells and 5 and 10 µM of 
selenite). This shows that Se metabolism tolerance of Se might be cell specific.  
Importantly, Jiang and co-workers (2000) found that 5 µM of methylselenol and 10 
µM of selenite reduced cell viability and tube formation in HUVECs post 72 hours of 
treatment. In their study, cells were treated with Se sources when already seeded 
into the Matrigel®, whereas in our study, cells were treated for 24 hours with high 
selenite (5 µM and 10 µM) and treatment was followed by seeding on the Matrigel®.  
Our study is the first to report the role of ER stress in impaired angiogenesis 
because of high Se concentrations. The results in Figure 5.1 showed that with co-
treatment of PBA and selenite, the angiogenic capacity of endothelial cells was 
preserved, as PBA significantly prevented impaired angiogenesis in HUVECs treated 
with 5 µM and 10 µM selenite. PBA has been shown to prevent or reverse ER stress 
induction in several animal models and cell lines (Hotamisligil, 1999; Ozcan et al., 
2006; Kuang et al., 2010; Liu et al., 2016). 
 
One study demonstrates the effect of high Se in the expression of VEGF-A, a 
regulator for angiogenesis (Shibuya, 2011; Johnson and Wilgus, 2014). It was crucial 
to therefore investigate the role of VEGF-A in Se induced endothelial dysfunction. 
Our results show that high Se reduces the expression of VEGF-A in a time 
dependant manner (compare Figure 5.2 panels A and B). Oxygen tension has been 
shown to be the key regulator of VEGF-A gene expression in vivo and in vitro. Under 
hypoxic state VEGF-A mRNA expression is induced through the activation of 
hypoxia inducing factor-1α (HIF-1α) in normal and transformed cultured cells as well 
as under ischemic injury in humans and animal models. Therefore VEGF-A is a 
mediator of spontaneous revascularisation following myocardial ischemia and in 
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wound repairing (Banai et al., 1994; Ferrara, 1999). Results from previous chapters 
have shown that selenite induced reactive oxygen species making the environment 
hypoxic, we propose that ROS-induced hypoxia activates hypoxia initiation factor-1α 
(HIF1α) which in turn stimulates the expression of VEGF-A gene. VEGF-A then 
activated and maintain angiogenesis therefore our results suggest that HUVECs 
cells might undergo compensatory mechanism in the early hours after selenite 
treatment (8 hours). 5 and 10 µM of selenite (Figure 5.2B) significantly reduced gene 
expression of VEGF-A at 24 hours compared to 24 hours as shown in Figure 5.2C. It 
is well established that VEGF-A expression stimulate the activation of adhesion 
molecules such as vascular adhesion molecules-1 (VCAM-1) and as well as 
inflammatory molecules such as interleukin-6 and apoptotic markers Bcl-2 in 
endothelial cells (Carmeliet, 2005). Our study could potentially be further developed 
to investigate the expression of adhesion molecules and inflammatory markers due 
to increased VEGF-A mRNA expression at time points between 8 hours and 24 
hours to investigate the cellular coping mechanism involved before programmed cell 
death induction.  
 
Additionally, to validate the role of VEGF-A in Se induced impaired 
angiogenesis, we propose to further investigate the VEGF-A protein expression at 
different time points to fully appreciate the role of ER stress in VEGF-A regulated 
angiogenesis process. VEGF-A drives tumour angiogenesis and in normal 
physiological conditions drives formation of new blood vessels. As our results 
showed reduced gene expression of VEGF-A at 24 hours post selenite exposure, we 
investigated the effect high selenite in angiogenesis process. High Se concentrations 
in the form of selenite impaired formation of new blood vessels as depicted in Figure 
5.1. Our results correlate with several studies that Se supplementation and 
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increased selenoproteins impaired angiogenesis (Jiang et al., 1999; Streicher et al., 
2004; Shi et al., 2013). It is interesting to note that co-treating HUVECs with PBA, a 
chemical chaperone, prevented the effects of high selenite on tube formation as well 
as VEGF-A gene expression remained at basal levels like in untreated cells and 
under selenite physiological concentrations.  The results as shown in Figure 5.1 and 
Figure 5.2 suggests that Se induced ER stress is involved in impaired angiogenesis. 
5 and 10 µM of selenite completely prevented endothelial cells to perform the vital 
function of forming new blood vessels (tube-like structures) under Matrigel®, an in 
vitro angiogenesis assay.   
One study demonstrated that 5 µM and 10 µM of Se in the form of purified 
human Selenoprotein P (SelP) impaired VEGF-A-induced angiogenesis in HUVECs 
as well as endothelial cell immigration (Ishikura et al., 2014). The study used SelP 
instead of selenite as a source of Se, however the results correlate with our results. 
In human studies, it has been shown that patients given high Se sources such as 
Seleno-yeast 300ug/day in SELECT trial or selenomethionine in NHANES study, 
developed increased the risk of type 2 diabetes a risk factor for cardiovascular 
events (Bleys et al., 2009; Laclaustra et al., 2010; Rees et al., 2013). However the 
role of high Se intake and risk of CVD is contradictory and molecular mechanisms 
behind high risk of CVDs associated with high Se intake are under investigation. Our 
results show that ER stress mechanism might drive high Se-induced endothelial 
dysfunction. Cells pre-treated with the chemical chaperone PBA thought to act 
through inhibition of ER stress, significantly showed improved angiogenesis 
compared to cells treated with 5 µM and 10 µM of selenite only.  
  
Selenite is known to be toxic to cells. However, whether this toxicity is due to 
a direct toxic effect of the high Se dose or to the activation of regulated apoptotic 
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mechanisms where the activation of ER stress observed above may play a pivotal 
role, is not clear. Therefore, we decided to investigate the nature of the cell death 
pathway at play caused by high-Se treatment (10 µM) in endothelial cells. The UPR 
is initially activated as a pro-survival pathway to protect the cells from increased 
accumulation of misfolded and unfolded proteins within the ER; however chronic 
activation of UPR or ER stress can lead to apoptosis. Over-expression of CHOP has 
been reported to lead to cell-cycle arrest and apoptosis (Zhang and Kaufman, 2008; 
Claudio Hetz, 2012). Chop-/- mice exhibit reduced apoptosis in response to ER stress 
therefore CHOP plays an important role in apoptosis induced by ER stress 
(Oyadomari and Mori, 2004) . We have shown above that high Se caused induction 
of ER stress and we investigated the role of Se induced ER stress in apoptosis in 
endothelial cells; the connection between the two phenomena is not clear. To further 
confirm that cell death caused by high Se involves an apoptotic mechanism and to 
understand the role played by ER stress response in this effect, we labelled 
endothelial cells treated or not with Se in the presence or absence of a chemical 
chaperone (PBA) with 7-AAD and Annexin V and then analysed by flow cytometry. 
 
 Although, the reduction of cell viability indicates cell death in endothelial cells 
treated with high Se, the nature of this death is not identified. Interestingly, we found 
that selenite at higher doses, 5-20 μM, induces apoptosis; however, another form of 
inorganic Se ―selenate‖ did not induce apoptosis at human physiological doses. The 
difference between selenate and selenite might be due to their metabolism because 
selenite is absorbed passively into cells compared to selenate which is absorbed in a 
more regulated manner using selenate/OH- co-transport mechanism. This difference 
in uptake has not yet been investigated in the cell lines we utilised. Importantly, the 
pre-treatment of endothelial cells with the chemical chaperone, PBA, which is known 
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to increase ER homeostasis and reduce the ER stress response (Ozcan et al., 2006; 
Yam et al., 2007; Amin et al., 2012) ), completely prevented high-selenite mediated 
apoptosis, strongly suggesting the involvement of ER stress. 
 
ER stress activation may lead to cell death through various mechanisms; 
however, over-expression of the pro-apoptotic protein CHOP is by far the most 
important one (Araki, Oyadomari and Mori, 2003; Scull and Tabas, 2011; Flammer et 
al., 2012; Inagi, Ishimoto and Nangaku, 2014). CHOP can induce apoptosis through 
different mechanisms such as; i) interacting with members of the BCL-2 family 
proteins to down-regulate the transcription of anti-apoptotic protein BCL-2 resulting 
in activation of the pro-apoptotic proteins BAX and BAK and causing mitochondrial-
mediated apoptosis, ii) the activation of the calcium signaling pathway (activation of 
CaMKII) or finally through the activation of caspase family, chiefly caspases 3 and 12 
(Scull and Tabas, 2011). Chronic activation of the UPR activates pro-apoptotic 
mediators, JNK, TRAF2 and AKS1 through phosphorylation of IRE-1α. Activation of 
JNK, TRAF2 and ASK1 will eventually lead to the activation of caspase 3. Caspase 3 
is structurally similar to caspase 7 and might compensate for the lack of caspase 7; 
its role is to activate apoptosis. Therefore, ER stress signals are involved in 
activation of caspases 3/7 leading to mitochondrial dysfunction and apoptosis.  
 
Caspase activity has been associated with ER stress but the identity of the 
applicable caspases involved has not been confirmed. Caspases 3/7 are critical 
mediators of mitochondrial events of apoptosis. High Se concentrations were 
reported in cancer cell lines to cause cell death mediated by ER stress by increasing 
calcium mobilization and the activation of caspases-3 and 9 (Wu et al., 2005; 
Szegezdi et al., 2006; Guan et al., 2009; Xiang, Zhao and Zhong, 2009; Uguz and 
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Naziroglu, 2012). Consistent with these results, we found that high doses of selenite, 
5-20 µM, caused ER stress-mediated apoptosis through the activation of caspases 
3/7 in endothelial cells (Figure 5.4).  
 
A chemiluminescence test looking at the activation of the caspase 3/7 
enzymes was used to determine the involvement of caspases 3/7 in ER stress-
induced apoptosis observed in the presence of high Se. EA.hy926 endothelial cells 
were treated with varying doses (0.5, 5, 10 and 20 μM) of selenite in the presence or 
absence of PBA for either 8 hours or 24 hours. As a positive control, some cells were 
treated with staurosporine, an inhibitor of protein kinase C (PKC), at the 
concentration 1 M for 4 hours. Our data showed an increased activity of caspases 
3/7 at both 8 and 24 hours with high dose of selenite (5 μM). The involvement of ER 
stress in this phenomenon was highlighted by the complete reversal of high selenite-
induced increase in caspase 3/7 activity in the presence of the chemical chaperone 
PBA. 
 
Our results furthermore demonstrate the role of ER stress in Se induced 
endothelial dysfunction. Additionally, high Se intake impaired angiogenesis and 
activated apoptosis in normal human endothelial cells through ER stress induction. 
We demonstrate that high Se intake increases the risk of CVD through an ER stress 
dependent mechanism.  
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6. General Discussion 
 
Previous research has raised questions on the role of high Se in CVD because high 
Se has been shown to cause insulin resistance in animal models also increasing the 
risk of type 2 diabetes in Se replete populations supplemented with high Se. 
However, the role of high Se in CVD has shown to be ambiguous; importantly the 
direct effect of high Se on endothelial dysfunction and the molecular mechanisms 
involved are not yet established. Furthermore, high Se induces apoptosis mediated 
by ER-stress in prostate-cancer cell lines, adipocytes, human neurons and 
pancreatic β cells (Wu et al., 2005; Zu et al., 2006; Hwang et al., 2007; Wallenberg 
et al., 2014). This study shows that high Se causes endothelial dysfunction through 
induction of ER stress.  
6.1. High Se concentration induces ER stress in cells 
 
The present study is the first to report that high Se induces ER stress in vascular 
endothelial cells, i.e. human umbilical vein endothelial cells (HUVECs). The present 
study not only adds to the existing evidence that high Se induces ER stress in cell 
culture (Wu et al., 2005; Ozcan et al., 2006; Scull and Tabas, 2011; Sano and Reed, 
2013; Wallenberg et al., 2014) but that treatment with Se in the form of selenite 
induces several ER stress markers in a time- and dose-dependent manner, both at 
the mRNA and protein levels in endothelial cells and liver carcinoma cell lines. To 
the best of our knowledge, these findings are novel and have not been reported by 
other groups in endothelial cells or liver carcinoma cell lines.  
 
We were the first to show that high-Se induced ER stress in endothelial cells, 
but we also found that cell viability was reduced more prominently in endothelial cells 
and HepG2 cell lines than in HuH-7 cell lines with concentrations considered to be 
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high (5 µM and 10 µM). This is because both endothelial cells and HepG2 cells used 
were p53 wild type in contrast to HuH-7 which is p53 mutant. Cells with p53 mutation 
tend to escape apoptosis, prolonging cell proliferation and survival (Brosh and 
Rotter, 2009; Amaral et al., 2010). However, the doses used were not toxic to cells 
because the form of cell death observed was apoptosis and not necrosis, as evident 
from the apoptosis assay performed. 
 
Whilst we proved here that high Se induces ER stress in endothelial cells by 
using a chemical chaperone PBA, we recommend that in future, molecular genetic 
assays should be more specific to confirm our hypothesis. We recommend that 
knockdown or overexpression of one of the ER stress markers, such as PERK or 
CHOP, will confidently establish the involvement of high Se in ER-stress induction. It 
has been shown that cells with CHOP -/- have delayed ER-stress-induced cell death; 
at the same time over-expression of BiP in cells was shown to prevent ER stress 
induction (Oyadomari and Mori, 2004; Quick and Faison, 2012; Han et al., 2013). 
One more recommendation is that post-transcriptional activation should be assessed 
by looking at the protein markers, for example the ATF4, PERK and IRE1α ER stress 
markers. Chemical chaperones such as PBA have been shown to have an effect in 
upregulation of some ER-stress transcription factors in fibroblasts (Perlmutter et al., 
2006). Our results show that PBA prevented the accumulation of ROS in endothelial 
cells as well as alleviating NO production, hence we further assume that besides its 
function as a chemical chaperone, it also has anti-oxidant activity.  
 
Another limitation of the study is the sample size used to investigate the 
expression of BiP and p-eIF2α in endothelial cells. Even though more than five 
sample sizes were investigated, the western-blot technique was troublesome. The 
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signals of both BiP and p-eIF2α bands were not sufficient for the investigation. To 
further validate the experiments, a more robust method such as ELISA technique 
and immunohistochemistry could be used, despite being more expensive. Though 
our results are from two independent experiments, they both indicate that chronic 
use of high Se leads to ER-stress activation. This suggests that high Se intake may 
cause ER-stress activation, not only in endothelial cells but in hepatocytes, therefore 
affecting not only would the vasculature but the liver as well.  
6.2. ER stress induced by high Se leads to endothelial dysfunction 
 
This is first study to prove that ER stress induced by high Se causes endothelial 
dysfunction. Our results expand the knowledge of the effect of high Se on endothelial 
dysfunction and CVD. Importantly, this is the first study to prove that high Se impairs 
angiogenesis via endoplasmic reticulum stress. ROS have been implicated in the 
cause or result of ER stress induction (Kawasaki et al., 2012; Han et al., 2013; Urra 
et al., 2013; Wallenberg et al., 2014). Furthermore, increased production of ROS 
dampen down the availability of NO (Schulz, Gori and Münzel, 2011; Uy, McGlashan 
and Shaikh, 2011). At the same time, impaired NO signalling results in impaired 
vasodilation and impaired NO-mediated angiogenesis (Shibuya, 2011; Johnson and 
Wilgus, 2014) . All these factors cause endothelial dysfunction. The results not only 
indicate that high Se leads to endothelial dysfunction by impairing the NO signalling 
pathway, increasing ROS production and inhibiting angiogenesis, but also that ER 
stress is one of the mechanisms involved.  
 
The second important finding is that high Se intake causes endothelial cell 
death mediated via caspase 3/7 activation. Chronic ER stress activates caspase-
mediated apoptosis (Scull and Tabas, 2011; Han et al., 2013). Only one study, to the 
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best of our knowledge, determined the apoptotic signalling pathway induced by Se in 
promyelocytic leukemia cells (Guan et al., 2009). Therefore, our results reinforce 
those of Guan et al. (2009) showing that long-term exposure of endothelial cells to 
high Se concentration activated caspases and ROS, resulting in ER stress-mediated 
apoptosis. Our findings broadly suggest that long-term intake of high Se in a 
population with optimal serum Se will increase the risk of CVD by inducing ER-
stress-mediated endothelial dysfunction.  
 
The main limitation of the study is the use a chemical chaperone as an 
inhibitor of ER stress to investigate the mechanism involved in endothelial 
dysfunction induced by high Se. Although the literature shows that PBA inhibits ER-
stress-mediated disease such as insulin resistance and renal fibrosis in mice and 
cultured cells (Ozcan et al., 2006; Liu et al., 2016), it would have been more 
significant if we had opted for the use of molecular techniques such as knock-down 
or overexpression of molecular chaperones involved in UPR such as BiP and PERK.  
 
A further limitation is that the only vascular endothelial cells were used in the 
investigation. Future research should include the use of myocardial tissue, for 
example cardiomyocytes, to assess the effects on heart tissue in high Se 
intake/status and could also use animal models to investigate the CVD endpoints. 
Well-planned observational studies that include populations with both low and 
optimal serum Se status supplemented with Se supplements will be necessary to 
assess the impact of high Se on CVD.  We recommend that new clinical trials that 
investigate the use of high Se as an anti-cancer treatment in a Se replete population 
should monitor CVD risk, for example by measuring blood NO production. 
Furthermore, the general population must be educated on the use of Se 
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supplements and made aware of the potential risk of CVD and type 2 diabetes in a 
population with optimal serum Se status. We also recommend a study to investigate 
the effects of ER stress induced by high Se and oxidative stress on the insulin 
signalling pathway in endothelial cells. 
6.3. Summary 
 
Altogether, findings summarised in figure 6.1 indicate that high Se impairs the 
function of endothelial cells and the underpinning cellular mechanism is ER stress. 
These results provide the foundation for future animal and human studies to answer 
the question of whether high Se intake increase the risk of CVD. Furthermore, 
understanding the molecular and cellular mechanisms involved in high-Se-induced 
endothelial dysfunction will help in the monitoring the effects of using high Se as a 
cancer chemotherapy agent.  
 
This thesis additionally warns the public to be aware of the risks of the use of 
Se supplements as a prophylactic agent against oxidative-stress disease. We 
specifically advise the public to be aware of the Se status in their area before 
deciding to take a Se supplement. Lastly we discourage RCTs on the effect of Se 
supplements in populations that already have optimal serum/plasma Se; same 
conclusion from selenium and prostate cancer studies (Lippman et al., 2009; Kristal 
et al., 2014).   
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Figure 6.1. Summary of mechanism by which high Se induces endothelial 
dysfunction through ER stress activation. High Se activates ER stress induction 
in endothelial cells. High Se-induced ER stress inhibits the phosphorylation of protein 
kinase C also known as Akt which further impairs NO signalling via reduced 
phosphorylation of eNOs. Both ROA and ER stress induced caspase 3/7 activating 
leading to ER stress mediated apoptosis. Moreover, reduced availability of NO leads 
to inhibition of angiogenesis. Overall impaired angiogenesis, reduced NO and 
apoptosis results in endothelial dysfunction.  
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